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Influenza A viruses (IAVs) infect many animal species including human (1), avian 
(2), swine (3), equine (4), canine (5), feline (6), some marine mammals (7) and 
bats (8).  Zoonotic IAV infections happen worldwide and are considered a major 
public health risk because IAVs can cause human pandemics (9). A novel IAV 
caused the 1st human pandemic of the 21st century and highlighted the role of the 
pig in the ecology of IAVs because the 2009 pandemic virus emerged from IAVs 
circulating in pigs in North America and Asia (10). In humans and pigs, IAVs are 
a main cause of respiratory disease and multiple interspecies transmission 
(human-pig) events have been documented (11-13). However, only one swine-
origin influenza virus, the 2009 pandemic virus, has adapted to humans and 
acquired human-to-human transmission (9, 10, 14). In contrast, several human 
influenza viruses have become established in swine populations (15). More 
extensive studies of the molecular biology and epidemiology of IAVs in pigs could 
help determine the emergence of novel IAVs with zoonotic and pandemic 
potential.  
 
Different epidemiological studies have evaluated the exposure, transmission, and 
distribution of swine IAVs around the world using serological tests or more recent 
IAV detection methods (3, 16-18). However, there is a gap in knowledge about 
what happens at the herd level, specifically between the epidemiological findings 
during IAV infection of pigs and the molecular information obtained from the 
virus. Swine IAVs are distributed worldwide and direct contact with infected pigs 
is considered the main route of transmission (3) although fomites (19) and 
airborne transmission may also play a key role in the spread of swine IAVs (20). 
Additionally, the main antigens of IAVs (hemagglutinin and neuraminidase) may 
differ by more than 60% (21, 22) illustrating the wide diversity of the viruses. 
Furthermore, in the last 20 years the genetic makeup of swine IAVs has changed 
significantly (17, 23). Nevertheless, viruses cannot replicate without their host 
and infected individuals can transport the virus to distant locations. Therefore, pig 
movements (regionally and globally) are associated with the genetic diversity and 
evolution of swine IAVs (13, 24) and highlight the significance of the host on virus 
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evolution and diversity.  Moreover, pig production systems have evolved into 
highly efficient farms that are concentrated in certain parts of the world (25-28). 
Pig turnover rates and animal movements within and between farms make viral 
infections harder to control. Although animal flows and biosecurity practices are 
in place to prevent other viral infections (29-32), the factors that increase the risk 
of IAV infection are not clearly understood.  
 
IAVs are commonly found among pigs (17) and represent a significant cost to 
producers (33, 34). In addition, IAVs can persist at the herd level for prolonged 
periods of time and one or more IAV subtypes can circulate over time within the 
same farm (3, 17, 18). However the epidemiological characteristics and 
molecular traits of IAVs that allow the long-term persistence of the virus in pig 
farms are not clearly understood. It is not clear if the genetic evolution within 
farms is responsible for virus persistence at the herd level or if there are repeated 
introductions of IAVs into pig herds.  Moreover, different pig subpopulations are 
housed within the same farm (e.g piglets, sows, and replacement animals) and it 
is not clear if these subpopulations harbor the same or different IAVs over time. 
Furthermore, in breeding herds replacement animals (gilts) are introduced on a 
regular basis but their role in IAV epidemiology is unknown. Gilts and newborn 
piglets could represent important subpopulations in which IAVs may replicate 
continuously over time.  
 
Once pigs are born they may be exposed to different IAVs under a variety of 
immunological circumstances and develop diverse immune responses 
accordingly. Pigs are born naïve to all IAVs because infection does not take 
place in-utero (35). Furthermore, there is no antibody transfer before birth (36). 
Then, after birth maternally derived antibodies (MDA) can be transferred to 
suckling piglets in colostrum, depending on previous exposure of sows to IAVs. 
The effect of MDA on IAV genetic diversity is not clearly understood. However, 
the genetic diversity of IAVs during infection of pigs with active immunity to 
multiple IAVs has not been characterized.  
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Understanding the transmission dynamics and genetic diversity of swine IAVs at 
the herd level should allow us to design better health interventions to control the 
disease in pigs, minimize IAV’s effect on swine health and production, and 
reduce the public health risk. Moreover, understanding the molecular dynamics 
of IAV genome at the individual and population levels during natural and 
experimental infections will help us understand the genetic diversity among 
individual hosts.  
 
Overall we hypothesize that the immune status of the pig is a key driver of the 
molecular evolution of the virus and that viral diversity alters the course of IAV 
infection. We also propose that different pig subpopulations on swine farms play 
unique roles in the persistence of IAVs over time. Therefore the main objective of 
this dissertation was to characterize the genetic diversity of IAVs during infection 
of pigs to better understand the epidemiology of swine influenza, focusing in 
particular on what happens at the herd level. Classical epidemiological methods 
and novel experimental designs were integrated with deep genome sequencing 
technologies and bioinformatics algorithms to produce robust evidence that 
supports the genetic plasticity of IAVs and contributes to the understanding of 
virus persistence at the herd level. The specific aims of this dissertation are to: 
 
1. Define patterns of IAV infection in pig subpopulations in IAV infected 
breeding herds.  
2. Assess and compare the genetic diversity of IAVs isolated over time from 
endemically infected breeding herds to estimate how long IAVs can persist 
at the population level.  
3. Evaluate the antigenic drift of an H1N1 IAV during infection of weaned 
pigs with or without passive immunity. 
4. Evaluate the genetic diversity of the complete genome of a triple 
reassortant H1N1 IAV population during experimental infection of 
vaccinated pigs. 
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5. Characterize, under field conditions, the epidemiology and molecular traits 
of IAVs infection in pigs after weaning.  
 
These objectives were achieved in different studies that focused first on 
commercial pig-breeding herds and then in weaned pigs under both experimental 
and field conditions. Understanding the epidemiology (objective 1) and genetic 
diversity (objective 2) of swine IAVs at the breeding herd level is crucial to 
minimize the distribution of IAVs to other locations after pigs are weaned.  
Then, studies on weaned pigs were conducted to understand the genetic 
variability of IAVs under different immunological conditions. These studies 
included determining the genetic diversity of the hemagglutinin of an H1N1 IAV 
was studied during infection of pigs with or without maternal immunity (objective 
3); then, the complete genome of the virus was studied during IAV infection of 
pigs with immunity to different IAVs (objective 4); and lastly we studied the 
epidemiology and molecular traits of different IAVs during infection of pigs after 
weaning under field conditions (objective 5).  
 
In these studies, models of IAV transmission and evolution included immune and 
non-immune pigs, and more importantly, pigs with passive immunity. Passive 
immunity in pigs plays a central role in IAV control and transmission since pigs 
with passive immunity sustain virus replication despite the lack of clinical signs 
(37, 38), which may represent ideal conditions for virus evolution. Moreover, two 
longitudinal field studies were developed in order to fully represent complex 
scenarios in swine IAV ecology. The combination of experimental and field 
settings to address complex questions using novel technologies yielded robust 
evidence regarding swine IAV epidemiology and evolution, which resulted in the 
translational application of the research findings to the swine industry. 
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Influenza A virus (IAV) and susceptible host species:  
 
Influenza A viruses (IAVs) are enveloped single stranded negative sense RNA 
viruses (-ssRNAv) that belong to the Orthomyxoviridae family (39). IAV genome 
is segmented in eight gene segments namely polymerase B2 (PB2, segment 1), 
polymerase B1 (PB1, segment 2), polymerase A (PA, segment 3), hemagglutinin 
(HA, segment 4), nucleoprotein (NP, segment 5), neuraminidase (NA, segment 
6), matrix (M, segment 7), and non-structural protein (NS, segment 8). From 
these gene segments, at least eleven different proteins are translated (Table 1) 
and among them the hemagglutinin (HA) and neuraminidase (NA) proteins are 
considered the main antigens of the virus. HA and NA also used to classify  the 
IAV subtypes and to guide IAV vaccine selection in many animal species 
including humans (40). There are at least 17 different HAs and 9 NAs (8, 9) 
although only a few HA-NA combinations have been reported in pigs (16, 18). 
Overall, the genetic diversity and evolution of IAVs is determined by multiple 
factors including the molecular characteristics of the virus, the host species, the 
immune responses, epidemics, and pandemics (1, 2, 9, 10, 41, 42).  
 
Avian species within the orders Anseriformes and Charadriformes are the natural 
reservoirs for IAVs (9). However, IAVs can infect other animal species including 
human (43), swine (3), equine (4), canine (5), feline (6), some marine mammals 
(7) and bats (8). The molecular mechanisms that allow IAV to cross inter-species 
barriers are not clearly understood (9, 44). However, the HA affinity for cell 
receptors plays a key role in host species range (39, 45-47). While avian viruses 
have greater affinity to bind to cell receptors that have sialic acid linked to the 
penultimate galactose in an α2-3 configuration (expressed more frequently in 
birds), human IAVs bind to α2-6 configured receptors (expressed more frequently 
in mammals). The HA is not the only determinant for IAVs host species ranges. 
For example, polymerases from avian IAVs do not perform efficiently in 
mammals (48). Moreover, pigs have both types of receptors for IAVs (α2-3 and 
α2-6) hence they are susceptible to infection to some mammalian and avian IAVs 
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(49). Interestingly, humans also possess both receptors on their cells for avian, 
human, and swine IAVs and zoonotic infections with avian or swine IAVs are 
continuously reported around the world (11, 50-52). 
 
Zoonotic IAVs are a major public health risk because such IAVs can lead to 
pandemics (10, 53). All IAV pandemics after the Spanish flu emerged from 
zoonotic and reassorted IAVs (9). Whether the 2009 pandemic strain emerged 
from a reassortment in pigs, humans or other animal species is still not clear. 
However, this pandemic virus highlighted the significance of swine IAVs for 
public health. Nevertheless, the 2009 pandemic virus has been the only swine 
IAV able to acquire human-to-human transmission after zoonotic infection (9, 10). 
In contrast several human IAVs are well established in swine populations (13, 15) 
and have contributed to the current diverse genetic landscape of swine IAVs (54-
56).  
 
Influenza A virus evolution and immune selection: 
 
Overall, RNA viruses change rapidly over time and IAVs are not the exception 
(44). A non-proof reading RNA-polymerase allows nucleotide mutations to 
accumulate over time during viral replication (48). The divergence of HA and NA 
genes over time is known as antigenic drift (39). In humans, HA has shown 
different rates of antigenic drift between subtypes, with  H3 changing faster than 
H1 variants (41). Moreover, substitution rates of human H3, but not H1, are 
characterized by long periods with higher numbers of synonymous mutations 
(stasis periods) followed by shorter intervals of rapid evolution where new 
dominant variants are established (57). Additionally, human H3 viruses have 
gene segments with different evolutionary patterns and origins that persist due to 
migration of meta-populations (58). Moreover, one study showed that IAV gene 
segments could evolve at different rates in different host species (59), which 
might be associated with the immunological responses to IAVs. Some results 
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indicate that human IAVs have higher mutation rates than swine IAVs (60) while 
a recent study indicated the opposite (61).  
 
The immune response to IAV is associated with antigenic drift in several animal 
species (41, 62, 63). Immune responses mediate IAV divergence over time 
because certain IAV strains (antigenically divergent) can evade the immune 
response and give origin to new genetic lineages. In swine, homologous 
immunity can minimize or prevent IAV transmission (38, 64). However, the effect 
of heterologous immunity on transmission and replication is not clearly 
understood. In animal models other than pigs, the original antigenic sin (OAS) 
phenomenon indicates that the immune response to new IAVs could be impaired 
if a previous exposure to a different IAV had happened (65). To my knowledge 
the OAS has not been investigated in detail for IAVs in pigs. Only one study 
indicates that the OAS phenomenon is not associated with the vaccine-
associated enhanced respiratory disease (VAERD) observed in pigs during some 
IAV infections (66). Studies of OAS in rabbits with antigens differing more than 
33 – 42% are not able to efficiently stimulate the memory immune system, and 
indicate that the homology between antigenic proteins is associated with the 
extent of immune recall (67). In humans, masking of epitopes of new IAV 
antigens with both pre-existing antibodies and with antibodies developed during 
the immune response drive the extent of the humoral immune response to IAVs 
(68). Furthermore, the memory humoral response to IAVs will depend on the 
amount of free antigen stimulating the immune system. However, IAV infection 
appears to be better at inducing antibodies to previous IAV antigens than IAV 
vaccination. Nevertheless, the characterization of the plasmoblast antibody 
response to IAVs in humans showed that vaccination to IAVs could induce the 
production of antibodies against IAVs circulating in previous seasons that were 
not contained in the vaccine used (69). These results in other animal species 
suggest that in pigs the interaction between IAVs and the immune status of the 
population could also play a key role in the emergence, persistence, and 
subsidence of IAVs over time. However, the antibody repertoire to IAVs in pig 
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populations and its relationship with IAV evolution is poorly understood and 
should be further investigated. 
 
The segmented genome of IAV allows gene reassortment to happen when two or 
more IAV particles infect the same cell (9, 39). Genetic reassortment can change 
abruptly the antigenic properties of IAVs (antigenic shift). Furthermore, 
reassortant IAVs are of public health concern because reassorted IAVs can 
cause pandemic IAV infections (9, 10). Genetic reassortment can also change 
viral pathogenesis without exchanging antigenic genes (when only internal genes 
are swapped) and complicates even more the understanding of IAV evolution 
and diversity within and between different species. Even though gene segment 
exchange has been demonstrated within and between species, little is known on 
the IAV gene flow in populations of endemically infected pigs. In other species 
reassortment appears to be random when IAVs are closely related to each other 
(70) and restrictive (not-random) when viruses from different genetic lineages 
exchange gene segments (71, 72). Nevertheless, the molecular mechanisms that 
drive swine IAV evolution and diversity could determine the health intervention 
practices required to minimize the impact of the disease in swine health and 
production and to reduce the public health risk. 
 
Epidemiology and genetic diversity of swine IAVs:  
 
Swine influenza was first described in 1918 coincidently with the Spanish flu 
pandemic (16). However, IAVs were not isolated from pigs until 1930 (classical 
H1N1, cH1N1). To date multiple IAV subtypes have been recovered from pigs 
(H1N1, H3N2, H1N2, H3N1, H4N6, H7N2, H9N2, and H5N1(3)). However only a 
few of these different subtypes transmit efficiently between pigs and are 
considered endemic in swine populations (H1N1, H3N2, and H1N2). Multiple IAV 
alleles (sequence variants of the same virus) can co-exist during IAV infection of 
pigs (73) and the same virus can evolve differently in the upper and lower 
respiratory tract of pigs (74).  
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The most prevalent swine IAV subtypes in North America (H1N1, H1N2, and 
H3N2) have phylogenetic origins in the classical H1N1 (cH1N1), the triple H3N2 
reassortant, the human H3N2 and the Eurasian swine H1N1 IAVs (13, 54-56, 61, 
75, 76). After the first isolation of IAV in 1930, and for almost 70 years, almost all 
swine IAVs isolated in North America were related to cH1N1. Then, in the late 
20th century multiple avian and human IAVs became established in swine 
populations (16, 61). However, it is not clear why “foreigner” IAVs (from humans 
and birds) only became established in swine populations until the last quarter of 
the last century and not before. Nevertheless, serological evidence indicates that 
human H3 were circulating within swine populations before becoming established 
(16).  
 
These multiple introductions of avian and human IAVs changed the genetic 
landscape of swine IAVs after 1998, when an outbreak of swine IAV in North 
Carolina and in Minnesota reported the introduction and maintenance of at least 
two different genotypes of H3 subtype into the US swine population. After this 
outbreak several different subtypes (H3N2, H1N2, human H1N1, and H3N1) 
containing  triple reassortant internal genes (TRIG) cassette were identified. This 
TRIG cassette was composed of PA and PB2 genes from the avian IAVs, NS, 
NP, and M from the cH1N1, and PB1 gene from the human IAVs (16). 
Interestingly, this internal gene constellation was maintained over time within 
many swine IAVs regardless of their subtype. However, after multiple 
reassortment events novel IAV gene constellations have emerged in North 
America (54, 75, 76). The frequency of reassortment among swine IAVs is not 
clearly understood. Only one study in Europe demonstrated that the rate of IAV 
reassortment is not the same for different IAV subtypes in swine but further 
investigation is required on this topic (72). Moreover, in 2009 the pandemic IAV 
placed “the pig” at the center of the “the mixing vessel” discussion because the 
pandemic virus contained gene segments from IAVs circulating in pigs in Asia 
and North America (10). Furthermore, during the pandemic more reassortment 
events happened with swine IAVs and illustrated how commonly virus 
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reassortment could take place among current and newly introduced viruses. 
Nevertheless, after the 2009 pandemic not all genes from the pandemic IAV 
remained circulating at the same level in the U.S pig population (75).  
 
At the HA level, swine IAVs in North America cluster in six antigenically and 
phylogenetically distinct H1 clades (α, β, γ1, γ2, δ1, and δ2 (56, 76)) and four H3 
clusters (I, II, III and IV (54, 75)). The genetic diversity of swine IAVs in the USA 
has been associated with the geographical distribution and movement of pigs 
(13, 24). Human viruses have become established in swine populations (15) and 
the Midwest appears to serve as an ecological niche for swine influenza viruses 
to reassort after they have originated from different areas of the country (13). 
Moreover, international trade of pigs is also considered a predictor of IAV flow 
from the USA and Europe to Asia (24, 77). IAV evolution is marked by the 
interaction of rapid mutation rates, viral selection, reassortment and worldwide 
epidemiological factors (9). In pigs, however, the host or herd factors influencing 
IAV evolution and diversity are not completely understood. 
 
Moreover, weaned pigs are main sources of IAVs and as a large subpopulation 
in the herd they appear to be an important herd factor to study. Weaned pigs can 
play a key role in the persistence of IAVs over time, They can be infected without 
showing any clinical signs (37), and transporting the virus to multiple 
geographical locations after weaning.  Additionally, piglets with or without passive 
immunity can shed IAVs (38) and multiple IAV subtypes can circulate in piglets 
before and after weaning (17, 18), which may facilitate the emergence of 
reassortant IAVs. However, little is known about genetic diversity and selective 
evolution of IAV in weaned piglets with or without immunity to IAVs. To my 
knowledge, there is only one published study that evaluated the effect of 
vaccination on the genetic evolution of IAV in pigs and in that study no 
differences were found in the mutation rate between pigs with or without active 
immunity to IAVs (73). However, the unknown variety of immune memory to IAVs 
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among pig populations could be associated with IAV genetic diversity and 
distribution. 
 
Swine IAVs are distributed worldwide and in the Midwestern USA 90% of the 
farms with growing pigs are positive to IAVs (17). In North America swine 
influenza was considered an epidemic disease with higher incidence rates in the 
late fall and early winter (16). However, the seasonality of swine influenza is not 
as marked as human influenza infections in temperate regions. Recent studies 
indicate that IAVs could be recovered from swine year round in endemically 
infected herds (17, 78, 79). Moreover, IAV infections in swine have a short 
incubation period (1-3 days) and animals recover within one-week post infection 
(16, 80, 81). Infected pigs are either sub-clinically infected or develop non-
specific clinical signs including high fever, coughing, sneezing, nasal discharge, 
decreased food intake, and conjunctivitis. After infection, IAV in pigs results in 
high morbidity (near 100%) and low mortality (<1%) (3, 16) and its incidence 
could be associated with the population immune status because transmission 
rates are different between naïve and immune animals (19, 64).  
 
The main transmission route of IAVs between pigs is direct contact (3). However, 
aerosols and fomites have been shown to be possible routes of transmission (19, 
20). Introduction of infected animals, and pig movement within and between 
herds can increase the risk of infection in swine populations. Weaned pigs are 
considered a source of IAVs to other swine populations (37). Additionally, 
newborn piglets and other naïve populations may play a key role in the reservoir 
and transmission of IAV within and between pig farms. However, viral 
persistence is not clear in endemically infected populations.  
 
Prevention and control  
 
IAV prevention and control in pigs is based on biosecurity practices and 
vaccination. However, strain selection for vaccines is complicated due to the 
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wide diversity of swine IAVs. Multiple commercial and autogenous vaccines are 
commonly used and have proven to reduce lesions, clinical signs and virus 
shedding (21, 64, 82, 83). Transmission might be reduced after vaccination but 
not eliminated, (64) and will depend on strain relatedness between circulating 
viruses and those used in the vaccines (21, 82). Furthermore, swine IAV 
vaccines are not updated systematically based on epidemiological surveillance 
as they are in humans. Regional dissemination of swine IAVs is highly suspected 
but its mechanism is still not well characterized. Measures toward the reduction 
of airborne pathogen introduction should be taken into account, as well as having 
bird-proofed facilities to keep birds out of pig herds. Furthermore, to better control 
IAVs, increased surveillance on swine IAVs is required in addition to new policies 
on IAV vaccination and control.  
 
Swine IAV diagnosis:  
 
Swine IAV diagnosis is basically based on pathology, serology, virus isolation 
and molecular detection of IAV gene segments (16, 83-85). IAV can induce 
respiratory clinical signs and lesions in pigs and, although the macroscopic and 
microscopic lesions associated to IAV are not always specific, they are 
sometimes highly characteristic. To be prudent, other etiological agents should 
be listed as differential diagnosis when IAV infections are considered. 
Furthermore, IAVs are part of the swine respiratory disease complex (86) thus 
IAVs are usually found with other respiratory pathogens during a respiratory 
outbreak. 
 
Serological tests are used to measure previous exposure to IAVs and include 
enzyme-linked immunosorbent assay (ELISA), hemagglutinin inhibition test (HI), 
and serum neutralizing (SN) tests (87). There are ELISA tests to detect 
antibodies against IAVs (88, 89) or IAV antigens; both ELISA tests (antibodies 
and antigen detection) use the NP of the virus because this protein is highly 
conserved among all IAVs. Additionally, the HA of IAVs agglutinate red blood 
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cells therefore serum samples could be tested for specific anti-HA antibodies 
using an HI test (90, 91). HI tests are useful for vaccine selection and are used 
by the World Health Organization to estimate when human IAV vaccines should 
be updated (40). SN tests measure the capability of a serum sample to inhibit 
IAV infection in cell cultures where the virus could grow in the absence of specific 
antibodies.  
 
Virus isolation is considered the gold standard for IAV diagnosis. However, 
molecular detection of IAVs can be more sensitive for IAV detection. Swine IAVs 
are usually grown in Madin-Darby canine kidney cells where cytopathic effect 
(CPE) can be observed within a week of cell culture infection (92). ELISA tests or 
molecular detection methods are used to confirm IAV isolation after CPE has 
been observed. Moreover reverse transcription real time polymerase chain 
reaction (RRT-PCR) is routinely used in the USA for the detection of swine IAVs. 
The United States Department of Agriculture (USDA) official test to detect swine 
IAVs by RRT-PCR targets the matrix gene of classical swine and pandemic IAVs 
(84). Furthermore, subtyping PCRs are available to differentiate H1N1 from, 
H1N2, H3N1 and H3N2 viruses. Nevertheless not all IAV positive samples can 
be subtyped using these methods, demonstrating the diversity among swine 
IAVs. IAV subtyping is inadequate for understanding the diversity and evolution 
of IAV within and between pig populations because viruses clustering within the 
same subtype could have evolved from different IAV lineages and could have 
different antigenic properties. Therefore, sequencing of swine IAV HA, NA and M 
gene segments has increased considerably in the last decade, especially after 
the 2009 IAV pandemic.  
 
Next generation sequencing technologies and complete IAV genome 
sequencing:  
 
Each IAV gene segment can be amplified in RT-PCR reactions and the PCR 
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amplicons can be used for genetic sequencing (85, 93). Different sequencing 
technologies are available for IAV sequencing. In the past, IAV gene segments 
were mostly amplified using “walking primers” and then sequenced using Sanger 
sequencing technologies. The Sanger technology allows long sequencing reads 
but low coverage (e.g 1 to 10X) because of the time required to read each base 
pair during the sequencing process (94, 95). Gene assembling using Sanger is 
easier and straightforward because the read length is longer. However, the 
detection of viral diversity is less likely when polymorphisms are present at low 
prevalence within the viral population.  
 
In contrast next generation sequencing technologies (NGS) do not require 
specific primers for genetic sequencing (96-98) and yield extremely high 
coverage (thousands to millions), where coverage refers to the number of times a 
given nucleotide position becomes sequenced. The coverage of NGS 
technologies allows a better characterization of IAVs and the identification of 
nucleotide polymorphisms of lower prevalence. NGS technologies are able to 
detect virus variants that are present at 0.1% within the virus population (99). 
However sequencing lengths are shorter and sequencing errors are higher 
compared to Sanger sequencing. Therefore sequencing assembling and 
metagenomes reconstructions are challenging. Nevertheless, new NGS 
platforms are improving their sequencing read length and new algorithms are 
available for sequencing assembly (97, 100, 101). Quality control and quality 
assurance can employ fastqc 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) during the 
bioinformatics analysis of NGS. During NGS, errors are more likely found within 
homopolymeric nucleotide sequences (repeats of the same nucleotide) and at 
the end of longer sequencing reads (98) . Therefore, to avoid overestimation of 
IAV diversity strict quality control and quality assurance procedures are required 
to trim sequencing reads with lower sequencing scores, and verify the accuracy 
of polymorphisms within homopolymeric regions (102). 
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Moreover, the conserved and complementary 3’ and 5’ ends of all IAV gene 
segments allow us to amplify the complete genome of the virus in a single RT-
PCR reaction (103). IAVs contain eight different gene segments that are very 
diverse between IAVs. However, all IAV gene segments (including those from 
different animal species) have 12 to13 nucleotides that are conserved and 
complementary at the 3’ and 5’ ends of each gene segment. Hence these 
conserved sequences can be used as primer targets to amplify the complete 
genome of IAVs in a single RRT-PCR reaction. Since NGS do not require 
specific primers for gene sequencing, the complete genome obtained from this 
single RRT-PCR reaction can be sequenced at once and then sorted 
bioinformatically by gene segment.  
 
Illumina Sequencing (one type of NGS) can yield a large amount (millions) of 
sequencing reads that range between 50 and 250 base pairs in length (96, 104). 
These reads can be analyzed as single reads or as pair ends which increases 
the accuracy of sequencing because takes into account nucleotides found in both 
directions (forward and reverse) (105, 106). There are two methods to assemble 
NGS sequencing reads, template based and de-novo assembly (105). In the 
template-based method, a known sequence template is used to map all NGS 
sequencing reads obtained. This means that each read is aligned to a template 
and if a threshold of percent pair wise identity is reached then the sequence is 
mapped to that region. The consensus (contig) sequence from all reads mapped 
is extracted and all reads that do not map to the template are discharged. In the 
case of IAVs one template can be used for each gene segment and one contig 
can be obtained for each sequence template used. For highly divergent genes 
(HA and NA) more than one reference template are used to increase the 
specificity of sequencing mapping. Reference based assembly is faster than de-
novo assembling because each read is only compared to the template and 
mapped or discharged. Additionally, if multiple IAV gene segments are co-
circulating within a sample and only one template for that gene segment is used 
only the most prevalent will be detected (the consensus). If the reference 
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template used for template based methods is divergent from the sample 
sequence some genetic variants might be missed. In contrast during de-novo 
assembly all NGS sequencing reads are compared among them and then all 
possible consensus (contigs) found are estimated. This process takes longer 
time because the number of comparisons increases exponentially with the 
number of NGS reads obtained. De-novo assembling can be useful to discover 
new IAV lineages.  
 
Swine influenza and the contemporary swine industry: 
 
Although the molecular characteristics of the virus and its natural relationship 
with the pig can drive IAV evolution it is possible that the structure of the 
contemporary swine industry is associated with the current diversity of swine 
IAVs. It has been mentioned before that pig movement within the USA, and 
between North America, Europe and Asia is associated with IAV gene flows (13, 
24, 77). Viruses are inanimate microorganisms that cannot replicate outside host 
cells. Hence it is axiomatic that pig movement will be associated with regional 
IAV genetic diversity because infected animals that are transported are moving 
viruses with them.  
 
Long-term persistence of IAV in populations has been reported in pigs before 
and after weaning and multiple reassortment events are well documented (17, 
23, 37). In humans, people movement around the world is associated with IAV 
introductions to naïve populations and confirms that human movements and 
intermingling contribute to  viral diversity (1). Nevertheless the roles of different 
pig subpopulations, and their movement within and among herds, on swine IAV 
diversity and evolution are not clearly understood. Furthermore, pork is the most 
consumed meat around the world. This high demand of pork has driven the 
industry, at least in the USA, to high efficiency farms with an average of 27 and 
24 piglets born and weaned every year respectively (25-27).   
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Pig farms are mostly organized into multi-site production systems, where 
different phases of production are located at separate geographical sites. 
Typically, breeding, gestation and farrowing take place in breed-to-wean 
(breeding) herds. At approximately 21 days of age, piglets are weaned and 
transported to a nursery or a wean-to-finish site where pigs are raised until 10 
weeks of age or to market-age, respectively. Breeding herds house replacement 
animals (gilts), adult females (sows), and piglets. Except on breeding farms 
where farrowing occurs in batches, typically piglets are born daily, with weekly 
births totaling about 40% of the resident adult female population. Adult females 
are replaced at a yearly rate of 45 to 55%, and replacement gilts are regularly 
introduced on schedules that range from 1 to 10 weeks or more across farms. As 
a result, breeding herd populations have high rates of turnover, which may be 
associated with fluctuating IAV susceptibility. For example, in a herd of 1000 
sows that weans 25 pigs per sow per year at 3 weeks of age, the expected 
suckling piglet population is approximately 1440 (larger than the sow population), 
and around 450 piglets are born each week. The implications for IAVs evolution 
and emergence of new strains in this population undergoing rapid turnover are 
not fully understood, but the continual availability of new susceptible hosts with 
different levels of immunity to IAVs (acquired or maternally derived) may favor 








Table 1. Influenza A virus gene segments and proteins translated 
Segment Name Number of Nucleotides* Protein(s) translated Function 
1 Polymerase base 2 (PB2) 2316 PB2 RNA Polymerase complex 
2 Polymerase base 1 (PB1) 2314 PB1 or PB1-F2 
RNA Polymerase complex 
Endonuclease and elongation activity 
PB1-F2: pro-apoptotic 
3 Polymerase acid (PA) 2250 PA 
RNA Polymerase complex 
Protease Activity 
4 Hemagglutinin (HA) 1776 HA 
Surface antigen 
Binding and fusion 




6 Neuraminidase (NA) 1410 NA 
Surface antigen 
Neuraminidase  
7 Matrix (M) 1030 M1/M2 
Matrix protein 
Membrane Protein 
Nuclear exportation Budding,  
Ion channel 
Assembly activity 
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Influenza A viruses (IAVs) are Orthomyxoviruses able to infect many animal 
species including birds, pigs and humans (9). The segmented genome of IAVs 
allows the exchange of gene segments between IAVs during infection and 
replication (2) facilitating the emergence of novel IAV reassortants with pandemic 
potential. The 2009 pandemic IAV contained genes from swine IAVs circulating 
in North America and Eurasia (53) and highlighted the importance of pigs in the 
ecology of IAVs among species.  
 
Influenza-like disease was first reported in pigs in 1918 at the time of the human 
Spanish flu pandemic and the virus was first isolated from pigs in 1930 (16, 107). 
Currently, IAV infections occur worldwide and are considered endemic in swine 
populations (107). In the US, IAVs have been present in pigs for many decades 
and several serological surveys conducted since the 1970’s have consistently 
demonstrated that IAVs are ubiquitous in swine (108-110). IAVs remained 
genetically stable in pigs in the US with minimal or undetected viral evolution until 
1998 when H3N2 reassortant viruses of swine, human and avian origin were 
detected in pigs (16). Subsequently new strains, new subtypes, and multiple 
reassortant viruses have been identified in pigs in North America (111, 112). 
There is evidence that multiple human introductions of IAVs, including the 2009 
H1N1 pandemic virus, into the pool of IAVs circulating in the US have greatly 
contributed to the increase of genetic diversity of the virus (15, 112). The 
contemporary swine farming methods and live animal movements between farms 
and geographical regions increase IAV diversity (13, 24) and make IAVs harder 
to control in swine populations. However, limited information is available about 
the frequency of IAV introduction and its maintenance within swine herds.  
 
IAV infections are common in the US Midwest, and herds can test positive year 
around with diverse viruses, regardless of the presence or absence of clinical 
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signs and vaccination status (17). Although influenza infections in individual pigs 
are of short duration (5-7 days), IAV infections of herds can be prolonged (weeks 
or months). When population dynamics, and extended IAVs circulation in pig 
farms are taken in consideration, the likelihood of reassortment increases (23, 
37). Furthermore the introduction of IAV strains of human origin broadens virus 
diversity in pigs (61) and this diversity is accentuated by the frequent movement 
of weaned pigs into swine-dense areas (13). 
 
The contemporary US swine industry is mostly organized into multi-site 
production systems. These systems have defined production stage facilities 
located in different geographical sites. Breeding, gestation and farrowing takes 
place in breed-to-wean (breeding) herds. At approximately 21 days of age, 
piglets are weaned and transported to a nursery or a wean-to-finish site where 
pigs are raised until 10 weeks of age or to market-age respectively. Breeding 
herds house replacement animals (gilts), adult females (sows), and piglets. 
Except on breeding farms where farrowing occurs in batches, typically piglets are 
born daily, with weekly births totaling about 40% of the resident adult female 
population. Adult females are replaced at a yearly rate of 45 to 55% (25), and 
replacement gilts are regularly introduced on schedules that range from 1 to 10 
weeks across farms. As a result, breeding populations have high rates of 
turnover, and associated fluctuations in herd’s susceptibility to IAV infections. 
Previous studies have shown that it is not easy to recover IAVs from sows (37, 
113, 114). However, the dynamics of IAV infection among other subpopulations 
(gilts and suckling piglets) may influence the maintenance of IAVs in the breeding 
herd or contribute to the emergence of novel strains. 
 
In this study, we aimed to define patterns of IAV infection in the most labile 
subpopulations on 5 IAV-infected breeding farms, with the goal of understanding 
the relative importance of these subpopulations as sources of new IAV infections 
in the breeding herd. This information is necessary to design targeted strategies 
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to control IAV infection within and between swine herds, and to minimize the risk 
of IAV infections of swine origin to people.  
 
Materials and methods 
 
Ethics statement:  
 
Protocols and procedures followed throughout the study were approved by the 
University of Minnesota Institutional Animal Care and Use Committee (IACUC 
1207B17281), and the Institutional Biosafety Committee (IBC 1208H18341). 
 
Study design and sample collection:  
 
Five commercial pig-breeding herds (Farms 1 to 5) located in the Midwestern 
USA were conveniently selected for this study. Selection criteria included breed-
to-wean herds with: a) confirmed IAV infection by real time reverse transcriptase 
polymerase chain reaction (RRT-PCR) within the past year, b) presence of an 
on-site gilt development unit (GDU), and c) introduction of external replacement 
animals into a defined isolation area. Each farm was visited monthly for 12 
months and the overall sampling period spanned from November 2011 to 
December 2012. At each visit, three pig subpopulations were sampled: a) 
replacement females, resident on-farm for less than 4 weeks (new gilts), b) 
replacement females, resident on-farm for more than 4 weeks (gilts), and c) 
neonatal pigs less than 21 days of age (piglets). Adult animals (sows) were not 
included since prior studies consistently reported a low probability of influenza 
detection in this subpopulation (37, 113, 114). Due to schedules for delivery of 
replacement females, eligible populations of new gilts were only present at 21 of 
the 60 sampling events. A diagram of the study design can be seen in Fig 1. 
Information on management and control practices for IAV was recorded during 
the last visit. 
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Thirty pigs were selected from each pig subpopulation (new gilts, gilts and 
piglets) and sampled individually using a nasal swab (BBL CultureSwab, Becton 
Dickinson and Company, USA).  Sample size (n=30) was estimated based on a 
95% confidence to detect at least 1 positive sample if prevalence was 10% or 
higher at the subpopulation level. After sample collection, nasal swabs were 
refrigerated and transported to the laboratory on the manufacturer’s transport 
media. At the laboratory, swabs were placed on 1.8 ml viral transport media 
(Dulbecco’s Modified Eagle Medium (DMEM) plus 5% antibiotic-antimycotic, 
Gibco Life technologies, USA) vortexed for 10 seconds, alliquoted and stored at -
80ºC until testing.  
 
Influenza A virus detection and subtyping: 
 
Nasal swabs were first screened for IAV by RRT-PCR on pools of three samples. 
If a pool tested positive then the samples comprising the pool were tested 
individually. All samples in a negative pool were considered negative. Viral RNA 
was eluted using 50 µl of each sample into 50 µl elution buffer using MagMax 
virus RNA isolation kit (Ambion, USA). Primers targeting the matrix (M) gene and 
AgPath-ID One-Step RT-PCR reagent kit (Ambion, Life technologies, USA) were 
used to detect IAV (84, 85). PCR mix containing 5 µl RNA, 12.5 µl 2X buffer, 1.0 
µl 25X enzyme mix, 1.67 µl detection enhancer, 5 pmol of each primer and 1.5 
pmol of probe was run on a LightCycler 480 system (Hoffmann-La Roche, 
Switzerland) at 45°C for 10 min, followed by 95°C for 10 min, and 45 cycles at 
94°C for 1 sec and 60°C for 30 sec. Fluorescence was recorded at 60°C and a 
sample was considered positive if the cycle threshold (CT) was lower than 40. 
Positive samples with a CT value of 35 or lower were used for IAV virus isolation 
on Madin–Darby Canine Kidney (MDCK) cells (92) and each IAV isolate was 





Data analysis:  
 
Data collected in the survey was summarized by farm and three independent 
variables were taken into consideration for statistical analysis: a) pig 
subpopulation, b) farm, and c) annual quarter (1st to 4th).  The association 
between IAV detection and subpopulation was analyzed at the group level where 
a group was defined as the subpopulation of pigs that was sampled during a 
given visit and considered positive if one or more swabs within the group tested 
positive to IAV. A Pearson’s Chi square or Fisher’s exact test was used to 
compare the frequency of IAV positive and negative outcomes by subpopulations 
(new gilts, gilts and piglets), farms (1 to 5), and annual quarter. Using gilts as the 
reference group, an unconditional logistic regression model was used to measure 
the crude association between the outcome and pig subpopulations, farm and 
annual quarter. Finally, fixed and mixed logistic regression models were 
compared to estimate the associations between IAV infection and subpopulation 
adjusting by farm, annual quarter, and sampling event. Subpopulation and 
annual quarter were included as fixed effects in the models, and clustering 
variables (e.g. farm and farm visit) were included as random effects. Given the 
study design (Fig 1) we assumed that samples clustered by sampling visit, farm, 
and annual quarter. We also assumed that pig subpopulations were nested 
within sampling visits, and that sampling visits were nested within farm. A Wald 
Chi-square was used to test the significance of individual coefficients within each 
model and a likelihood ratio Chi square test was used to compare hierarchical 
models. Statistical significance was assumed at p values lower than 0.05 and the 
model with the lowest Akaike information criterion (AIC) value was selected as 
the final model. All data analysis and graphics were performed using R 3.1.0 
(The R Foundation for statistical Computing, www.R-project.rog) and packages 
installed included lattice (115), gmodels, car, aod (116), ggplot (117) , lme4 (118) 






Between November 2011 and December 2012, 4190 individual nasal swabs 
were collected from 141 groups of pigs in the 5 pig-breeding herds. Farm 
demographics are summarized in Table 2. Among all groups sampled, 60 
(42.5%), 60 (42.5%) and 21 (15%) were groups of piglets, gilts and new gilts 
respectively. Swabs were collected from 1796 (43%) piglets, 1768 (42%) gilts 
and 626 (15%) new gilts. Although all farms and subpopulations under study 
tested positive to IAV at least once, only 28 groups (19.9%) and 324 swabs 
(7.7%) were positive for IAV. Piglets tested positive at least once in all farms, 
new gilts only tested positive in farms 1 and 3, and all gilts tested negative in 
farm 5 (Fig 2).  One hundred and twenty four IAVs isolates were recovered and 
123 of them were successfully subtyped. Subtypes H1N1, H1N2 and H3N2 were 
identified and more than one IAV subtype was isolated in all farms over time.  
 
No positive samples were found in May, June or September 2012 and the 
univariate analyses indicated that IAV infection was strongly associated (p<0.01) 
with pig subpopulation and annual quarter (Table 3). The crude odds of IAV 
infection in groups were higher for piglets and new gilts compared to groups of 
gilts, and lower for groups of pigs sampled during the second annual quarter 
(April, May, June) compared to any other quarter of the year (Table 4).  
 
The final multivariate model indicated that, after adjusting by annual quarter and 
sampling visit, the odds of IAV infection were higher in groups of new gilts 
(OR=7.9 95% CI: 1.4,43.9) and piglets (OR=4.4 95% CI: 1.1,17.1) compared to 
groups of gilts (Table 5). Inclusion of farm to the model was not statistically 








To advance our understanding of IAV epidemiology in swine breeding herds, we 
combined frequent sampling and PCR-based methods to define patterns of 
active IAV infections among pig subpopulations present in these herds. We found 
that replacement animals resident on-farm for less than 4 weeks (new gilts) and 
pigs less than 21 days of age (piglets) had higher odds of testing positive to IAVs 
compared to replacement animals resident on-farm for more than 4 weeks (gilts). 
Therefore new gilts and piglets may represent the most epidemiologically 
significant reservoirs for IAVs in swine breeding herds. Sows were not included in 
our study because they have been found to have a low probability of influenza 
positivity in endemically affected herds (37, 113, 114). Our results also indicate 
that there was a strong association between IAV infection and annual quarter 
and that this association was still statistically significant after controlling for the 
subpopulation effect.  
 
In the USA there are approximately 65 million commercial pigs, of which 
approximately 6 million are breeding sows.  Breeding females are replaced at a 
45-55% rate annually (i.e. approximately 3 million gilts are introduced every year 
into US sow farms to replace existing breeding stock), and each sow gives birth 
and weans approximately 27 and 24 piglets respectively (25). For example, in a 
herd of 1000 sows that weans 25 pigs per sow per year at 3 weeks of age, the 
expected suckling piglet population is approximately 1440 (larger than the sow 
population), and around 450 piglets are born each week. The implications for 
IAVs evolution and emergence of new strains in this population undergoing rapid 
turnover are not fully understood, but the continual availability of new susceptible 
hosts with different levels of immunity to IAVs (acquired or maternally derived) 
may favor emergence of new variants. 
 
Most published studies to date have studied IAV transmission at a broad scale 
based on the genetic evolution of IAV throughout time and space (13, 15, 24, 
 29 
61), and relatively limited information is available on the epidemiology of IAVs at 
the herd level.  Furthermore, most herd level studies have used serological 
methods rather than direct detection of the virus by molecular methods (120-
122). Serological results are less definitive and can be difficult to interpret since 
detected antibodies may reflect maternally derived antibodies or active immunity 
to IAV infection or vaccination, none of which can be distinguished from the 
other.  
 
This study demonstrates that in certain breeding herds, new gilts and piglets can 
be an important reservoir for IAVs in swine populations. New gilts represented 
animals from an external source and could have been naïve to resident farm 
viruses or a source of new IAVs to the breeding herd. Upon arrival to a farm, new 
gilts were commonly kept in a separate room or building (although rarely in 
complete isolation) to minimize introduction of new diseases for approximately 30 
days. After that, gilts were moved into the gilt development unit. We selected 4 
weeks as the cut-off to classify gilts (new gilts or gilts) to reflect this industry 
practice of gilt management. Our results then showed that gilts had lower odds of 
IAV infection.  One possible explanation is that gilts have been able to clear the 
infection since they have been on site for a longer period of time. IAV infections 
at the individual animal level are self-limiting and usually last between 5 to 7 days 
(16). In contrast, finding IAVs more frequently in new gilts may reflect the 
introduction of infected animals from the source herds. Although in this study we 
did not sample the source herds, the likelihood of these herds to be IAV positive 
is high given the commonality of IAV infections in the Midwest (17). However, we 
cannot fully rule out the possibility that new gilts became infected with resident 
viruses after arrival to the herd. Although new gilts were placed into isolated 
designated areas and procedures were in place to minimize disease 
transmission (eg. isolation, vaccination), these areas or procedures might not 
have been able to fully contain infections within the designated areas. Future 
studies sampling gilts at arrival to the breeding herd would be required to more 
precisely estimate the risk of gilts at introducing IAVs into breeding herds. 
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Nevertheless our study identified new gilts as a subpopulation that tested IAV 
positive more frequently than resident gilts which indicates the need to have 
specific control programs or protocols to mitigate their risk.  
 
In contrast, neonatal piglets at birth are immunologically naïve and likely acquire 
IAV infection within the breeding herd. The role of piglets in maintenance and 
dissemination of IAV infections has been documented before (37). In this study 
we support those findings although our study design did not discern whether 
infections in piglets in consecutive months were due to endemic viruses 
maintained in this subpopulation, or whether they represented new infections 
from other subpopulations. Previous studies have shown that different IAV 
subtypes can co-circulate, be sustained (17) and reassort (23) in swine 
populations. In this study we also demonstrate that different IAV subtypes can be 
present simultaneously in breeding herds. Further studies on the complete 
genome characterization and phylogenetic analysis of the viruses recovered from 
these subpopulations will be able to assess virus diversity and reassortment 
within these pig subpopulations. Additionally, our study measured the odds of 
IAV infection based on the detection of the matrix gene. The matrix gene 
segment is highly conserved among IAVs. Whether the odds of IAV infection in 
pig subpopulations varies for different IAV subtypes should also be further 
investigated.  
 
Time of the year when IAV infection was detected was also associated with IAV 
infection in our study. In humans, IAV infections have a clear seasonal pattern in 
temperate regions but the pattern is less defined in the tropics (43). In swine, 
IAVs seasonality is still under debate (17, 75, 78). One recent study in Europe 
did not detect any seasonal trend of swine IAV (18). In another study, season 
(winter) and IAV like-illness in pigs were strongly associated but IAVs detection in 
pigs and season were not (78). In our study, we found higher odds of IAV 
detection in groups of pigs sampled during the first quarter of the year (winter in 
the northern hemisphere), thus favoring the hypothesis of a seasonal trend of 
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swine IAV. The differences among studies may be due to study design, sample 
size, and the result of measuring these associations using active or passive 
surveillance.  
 
We acknowledge that our results do not represent IAV infection dynamics across 
U.S herds since only a limited number of herds participated in the study and 
these herds were conveniently selected.  In addition, we identified significant 
variability in the number of IAV infected pigs between sampling events, which 
may be a reflection of the sample size or number of farms in the study. However, 
our IAV detection rates are similar to those described in other studies and our 
sample size for each of the farms is larger than in other studies (3).  
 
In conclusion, our study indicates that there are differences in the odds of IAV 
infection across different pig subpopulations found in breeding herds, and that 
IAVs can be found more frequently in new gilts and piglets than in resident gilts. 
Our results also indicate that there is a strong seasonal component to IAV 
infection in breeding herds from this study with the first quarter of the year being 
the period with most positives. Overall our results contribute to better understand 
IAV transmission in pigs and indicate the need to focus interventions to control 













Table 2. Descriptive Farm Demographics.  
 
 
1Age range for new gilts at arrival in farm four was between 8 and 24 weeks. For 





















Table 3 Number (%) of pig groups positive to influenza A virus by RRT-PCR 
distributed by subpopulation, farm, and annual quarter.  
A group was considered positive if at least one swab within the group was IAV 
RRT-PCR positive. The proportion of positive vs. negative outcomes by 
subpopulation, farm, and annual quarter was compared using a Pearson chi-









Table 4. Results from the univariate analysis.  
The crude association between IAV detection and subpopulation or annual 
quarter was measured through odds ratios. A group was considered positive if 
one or more swabs within the group tested positive to IAV by RRT-PCR. The first 
group for each variable of interest was used as the reference group.  
 
 



















Table 5. Results from the multivariate analysis (Mixed effects model).  
While subpopulation and annual quarter were included as fix effects, sampling 
visit was included as random effect.  
 
 





















Figure 1. Study design.  
Five swine-breeding herds (largest rectangles, 1 to 5) in the Midwest were 
sampled between November 2011 (month 1) and December 2012 (month 14). 
White rectangles represent sampling visits (12 per farm), and the smallest 
rectangles (n=141) indicate the groups of pigs sampled. Groups are colored 
based on pig subpopulation: yellow (new gilts, n=21), green (gilts, n=60), and 
purple (piglets, n=60). Missing group-rectangles indicate that there were no new 
gilts on that visit. Groups were assumed nested within sampling events, and 









Figure 2. Percentage of influenza A virus positive samples distributed by 















Chapter 3: Deep genome sequencing of Influenza A viruses in 
pig breeding herds reveals the emergence, persistence, and 






















In 2009, a novel influenza A virus (IAV) that emerged from swine caused the first 
human IAV pandemic of the 21st Century and changed perceptions of the role of 
pigs in the ecology of IAV infections (10). IAV infections are endemic in many 
species including wild waterfowl (123), humans (43), and pigs (16, 86). IAVs can 
also infect poultry (124, 125), horses (126), cats (6), dogs (5), some marine 
mammals (7) and a distant genetic lineage of IAV has been recently identified in 
bats (8, 45). Zoonotic IAVs can cause pandemic infections (10), however not all 
zoonotic IAV infections exhibit sustained human-to-human transmission (12, 47). 
Except for the 2009 pandemic, no other swine-origin transmission of IAV has 
acquired the ability to transmit effectively human-to-human; however, several 
reverse zoonotic events have resulted in human-IAVs to becoming well 
established in swine populations (13, 15, 61).  
 
IAVs are Orthomyxoviruses with eight single stranded negative sense RNA gene 
segments that translate at least 12 different proteins (9). IAV genome segments 
include polymerase B2 (PB2, segment 1), polymerase B1 (PB1, segment 2), 
polymerase A (PA, segment 3), hemagglutinin (HA, segment 4), nucleoprotein 
(NP, segment 5), neuraminidase (NA, segment 6), matrix (M, segment 7), and 
non-structural protein (NS, segment 8). RNA viruses change rapidly over time 
(44), and IAVs are no exception. However, not all IAV gene segments change at 
the same rate and substitution rates can be host-species specific (59). 
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Additionally, the segmented nature of the IAV genome allows two or more IAVs 
to exchange gene segments (reassort) during replication (70, 71) increasing 
factorially the potential for virus diversification. IAVs are commonly found in North 
American swine herds (37, 113, 114) where H1N1, H1N2, and H3N2 subtypes 
are frequently identified (17). At the HA level, these IAVs cluster in six 
antigenically and phylogenetically distinct H1 clades (α, β, γ1, γ2, δ1, and δ2) 
(55, 76) and four H3 clusters (I, II, III and IV) (54). The genetic diversity of IAVs in 
United States (US) pigs has been associated with the geographical distribution 
and movement of pigs (13) and the international trade of pigs is considered a 
predictor pathway of genetically-related IAVs being introduced from the US and 
Europe to Asia (24, 77).  
 
In the contemporary US swine industry, there are almost 70 million pigs, which 
include 6 million breeding stock. Breeding, gestation and farrowing takes place in 
breeding herds (127). Then, at about 21 days of age piglets are commonly 
weaned and transported to a separate site to be reared to the next production 
phase or until market (25). Pig breeding herds house different types of pig 
subpopulations with different turnover rates and different susceptibilities to IAV 
infection (128). These sub-populations include sows (mothers of piglets), 
replacement animals for the sows (gilts), and piglets (pigs from birth to weaning).  
Gilts are introduced on a regular basis to the breeding herd and replace sows at 
a yearly rate of 45 to 55% (25). Moreover, suckling piglets represent 
approximately 40% of the resident adult female population and every week 
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newborn piglets replace those pigs that are being weaned. Therefore breeding 
herds are dynamic populations and suckling piglets represent the largest 
population and have the highest turnover rate among all different pig 
subpopulations present.  
 
Despite all the knowledge gained on IAV diversity in pigs as a result of the 
increased surveillance efforts of the last few years, there is limited information on 
the genetic diversity and virus evolution observed at the herd level. We 
hypothesize that the population dynamics present in pig breeding herds play a 
key role in the introduction, emergence, and persistence of IAV over time. 
Different pig subpopulations, with their respective turnover rates, may represent 
different ecological niches for IAV replication and evolution. Understanding the 
evolution and diversity of IAVs among swine subpopulations in breeding herds is 
crucial to unravel the mechanisms by which IAVs persist for prolonged periods of 
time in these herds; therefore, we characterized the complete genome of IAVs 
during infection of pigs under natural conditions and demonstrated the complex 
and dynamic occurrence and maintenance of IAVs in pig subpopulations that are 
present in pig breeding herds.  Results from this study provided a deeper 
understanding of IAV persistence at the herd level, knowledge that is required to 
design more effective health interventions to control IAV infection in pigs and 
reduce its zoonotic potential.   
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Materials and methods 
 
Ethics statement  
Protocols and procedures followed throughout the study were approved by the 
University of Minnesota Institutional Animal Care and Use Committee (IACUC 
1207B17281), and the Institutional Biosafety Committee (IBC 1208H18341).  
Study design, IAV detection and isolation: 
 
We designed a longitudinal study with multiple cross-sectional sampling events 
to detect and characterize IAV infections in five commercial pig breeding herds 
(Farm 1 to 5) located in the Midwestern, USA. More specifically we evaluated at 
the farm level the emergence (first isolation of an IAV), persistence (the same 
IAV lineage detected over time), and subsidence (no further isolation of an IAV 
previously recovered) of IAVs in these five herds. All farms had a history of IAV 
infection and were conveniently selected on November 2011 and sampled on a 
monthly basis for 12 months. During each farm visit, 30 nasal swabs (BBL 
CultureSwab, Becton Dickinson and Company, USA) were collected from three 
pig subpopulations: 1) new gilts (replacement breeding stock on farm for less than 4 
weeks), 2) gilts (replacement breeding stock on farm for more than 4 weeks) and, 3) 
piglets (3 week-old suckling pigs). Sows were not sampled because previous 
studies have found that recovering IAVs from sows is frequently unsuccessful 
(37, 113, 114). Sample size (n=30) was calculated at the subpopulation level with 
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a 95% confidence level to detect at least 1 positive sample if the prevalence was 
10% or higher. Overall, new gilts were sampled during 21 visits due to varying 
schedules of the delivery of replacement animals. Once collected, swabs were 
refrigerated and transported to the laboratory on the manufacture’s transport 
media and then placed into 1.8 ml sample storing media (Dulbecco’s Modified 
Eagle Medium (DMEM), 2% bovine serum albumin (BSA) fraction V 7.5% 
solution (Gibco, Life technologies, USA), 5% antibiotic-antimycotic (Gibco, Life 
Technologies, USA containing 10000 IU/ml of penicillin, 10000 µg/ml of 
streptomycin, and 25 µg /ml of Fungizone)). Swabs in the sample storing media 
were vortexed for 10 seconds, and then stored at -80ºC until IAV testing.  
 
Samples were initially tested for IAV in pools of three by reverse transcriptase 
real time polymerase chain reaction (RRT-PCR) targeting the matrix gene using 
methods described elsewhere (84, 85). Each pool contained only samples from 
the same farm, month and subpopulation. If a pool tested positive then aliquots 
of the original samples were tested individually. A test was considered positive 
when the RRT-PCR cycle threshold (Ct) value was lower than 40 and IAV 
isolation was attempted from all swabs with a Ct value < 35. Madin–Darby canine 
kidney (MDCK) epithelial cells were used for IAV isolation (92). Briefly, one six 
well plate (Corning, Sigma-Aldrich, USA) was used per sample to avoid cross 
contamination between samples and two negative controls were used per plate. 
When the cell monolayer was ~90% confluent the cell growth media was 
discharged and then each well was washed twice with Hank’s solution (Gibco, 
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Life technologies, USA) containing 0.15% 1mg/ml TPCK trypsin (Sigma-Aldrich, 
USA). 200 µl of 1:1 and 1:2 dilution of the sample were used in replicates to 
infect 4 wells of each plate and the two negative controls were mock infected with 
200 µl of DMEM (Gibco, Life technologies, USA). Plates were placed into a 5% 
CO2 incubator for an hour and then 2 ml of viral growth media was added to each 
well. Viral growth media contained DMEM (Gibco, Life technologies, USA), 4% 
bovine serum albumin (BSA) fraction V 7.5% solution (Gibco, Life technologies, 
USA), 0.15% 1mg/ml TPCK trypsin (Sigma-Aldrich, USA), and 1 % antibiotic-
antimycotic (Gibco, Life Technologies, USA). Plates were observed daily and 
harvested if IAV cytopathic effect (CPE) was visually confirmed. If no CPE was 
present, then wells were harvested at 7 days post infection for a blind passage in 
a new MDCK plate. A hemagglutination assay was performed on all wells 
harvested. If a well lacked CPE but was hemagglutination positive, a blind 
passage was performed on a new MDCK plate. IAV isolation was confirmed by 
CPE and antigen detection using swine influenza type A antigen test kit 
FluDetect (Zoetis, USA). Initial IAV positive isolates (passage 1) were expanded 
into T25 flasks (passage 2) and these second passages were used for complete 
genome amplification and sequencing. 
 
Complete genome amplification and sequencing: 
 
The complete genome of IAV was amplified in a single reaction as previously 
described (103). IAV RNA was extracted from positive isolates using MagMax 
 45 
Viral RNA isolation kit (Ambion, Life Technologies, USA). RRT-PCR was 
achieved using SuperScript III One-Step RT-PCR System with Platinum Taq 
DNA Polymerase (Invitrogen, Life Technologies, USA). A 50 µl PCR mix was 
prepared containing 10 µl DNase/RNase-Free distilled water (Gibco, USA), 25 µl 
2x reaction mix, 1 µl SuperScript III RT mix, 1 µl  (10 µM) of each primer 
(MBtuni12(M): ACGCGTGATCAGCRAAAGCAGG and MBtuni13: 
ACGCGTGATCAGTAGAAACAAGG), and 12 µl of RNA template. PCR products 
were verified by gel electrophoresis, purified using QIAquick Spin Kit (QIAGEN, 
USA), eluted in 20 DNase/RNase-free distilled water (Gibco, Life Technologies, 
USA) and submitted for next generation sequencing (NGS) using Illumina MiSeq 
system (Illumina, USA) at the University of Minnesota Genomics Center (UMGC).  
 
Sequencing data was analyzed through the resources available at the University 
of Minnesota Supercomputing Institute (MSI). Sequencing quality was first 
verified using FastQC (129) and then trimmed using the pair-end mode of 
Trimmomatic (102). Sequencing assembly was performed using Bowtie2 (130) 
and SAMTools (97) on a reference template containing 6 IAV internal gene 
segments (PB2 (CY099076.1), PB1 (CY099309.1), PA (CY045233.1), NP 
(CY009919.1), M (DQ150436.1), and NS (CY050162.1)) and 4 antigenic gene 
segments (H1 (FJ789832.1), H3 (KC992248.1), N1 (GU236519.1), N2 
(KC866483.1)). Consensus sequences for each contig assembled were trimmed 
to coding IAV gene regions and their functionality verified using the NCBI FLu 
Annotation web-service (FLAN (131)).  
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Phylogenetic origins and IAV diversity within and between farms: 
 
First, all IAV isolates from this study were classified based on the HA and NA and 
then specific phylogenetic relationships were estimated for each gene segment. 
Data sets for this analysis included the sequences from this study plus all 
complete swine IAV sequences from the USA (gene segments 1 to 8) 
downloaded from the Influenza Research Data Base (IRD (132)) on October 16th 
2014 and an additional data set from the United States Department of Agriculture 
(USDA), National Veterinary Service Laboratories (NVSL). Only IAVs collected 
between January 1st 2003 and October 16th 2014 with collection date 
(month/day/year) were kept, and 01/01/03 was set as day 1 for purposes of 
evaluating IAV evolution. Data sets for antigenic HA gene segment subtype H1 
was broken accordingly to Zell et al., 2013 (133) into lineage 1A (H1 classical-
swine), 1B (human seasonal H1). All other antigenic data sets (H3, N1, and N2) 
were kept as single genetic lineages. Additionally, data sets for segment 7 
(matrix) and 8 (non-structural) were broken into pandemic and non-pandemic 
sequences for a total of 13 IAV gene segment datasets. Each dataset was 
aligned using Multiple Sequence Comparison by Log-Expectation (MUSCLE 
(134)) and approximately maximum-likelihood trees were constructed for each 
dataset using FastTree2 (135), assuming a Generalized Time Reversible (GTR) 
substitution model. Local support values were estimated under the discrete 
gamma model (136) with 20 rate categories (Gamma20-based likelihood). The 
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best fitting root for each tree was found using Path-O-Gen v1.4 and a simple 
linear regression model was used to estimate the crude association between 
distance to the root of the phylogenetic tree and time (in days). Furthermore, the 
line fitted was used to estimate the x-intercept (distance to the root equal 0) and 
obtain a crude estimate of the time to most recent common ancestor (TMRCA) 
for each genetic lineage analyzed.  
 
The temporal distribution of IAV was compared within and between farms based 
on the HA lineage, and reassortment events were evaluated using the HA as a 
backbone. Additionally, sequences obtained from this study were aligned using 
ClustalX (137) and the pairwise distance between sequences used to estimate 
the genetic diversity of IAV isolates over time. Finally, hypothetical HAs and NAs 
were translated and polymorphic amino acids inferred. Briefly, HA and NA amino 
acid sequences were first aligned using ClustalX (cost matrix Blosum62) and 
then polymorphic sites were stripped to estimate the frequency of each amino 
acid. All graphics were performed using R 3.1.0 (The R Foundation for statistical 





One hundred and twenty four IAVs were isolated from 207 IAV RRT-PCR 
positive nasal swabs (Table 6) and the complete IAV genome was successfully 
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sequenced from 123 of these virus isolates. IAV isolates were obtained from new 
gilts (farm 3), gilts (farm 3 and 4) and piglets (farms 1-5). While H1N1 and H3N2 
viruses were isolated from farms 1-5, H1N2 viruses were only isolated from 
farms 2, 3 and 4. Ninety seven percent of virus isolates (n=120) contained a 
single IAV subtype with either H1N1 (n=31, 25.2%), H1N2 (n=26, 21.1%), or 
H3N2 (n=63, 51.2%) subtypes. However, three (2.5%) IAV isolates had a mixture 
of IAV subtypes and those were recovered from two gilts in farm 3 (H1N1/H3N2 
and H1N1/N2 respectively) and one piglet in farm 2 (H1N2/H3N2). Additionally, 
co-circulation of two or more IAV subtypes at one sampling period was confirmed 
at least once in all farms 
 
To understand the phylogenetic relationships of these 123 viruses, their gene 
segment sequences (n=1000) were compared to 14,401 sequences from IAVs 
circulating in the US between January 1st 2003 and October 16th 2014. For all 
swine IAV gene segments analyzed (Table 7) a linear association was present 
(p<0.05) between the distance-to-the-root of the phylogenetic tree and time (in 
days). Furthermore, 51% to 86% of the variability on the distance-to-the-root was 
explained by time. The nucleotide difference between sequences ranged 
between 4.64x10-6 (NS gene, segment 8) and 1.51x10-5 (NA, subtype N2, 
segment 6) for each day increment over time. Moreover, the 125 HA sequences 
from this study clustered within 7 different monophyletic clades (Gamma20 
based likelihood > 0.91 (min: 0.91 max: 0.99)). For this study, these seven HA 
clades were denominated study clades 1-7 (SC1 to SC7) and are illustrated in 
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Figs 3a, 3b and 3c. Study clades 1, 2 and 3 were H1 viruses although SC1 
viruses clustered with swine IAV gamma viruses while SC2 and SC3 clustered 
with swine IAV delta viruses (55, 56, 76). Furthermore, IAVs study clade 4, 5, 6, 
and 7 (Fig 3c) were all H3 viruses and clustered with H3 cluster IV (54). 
 
The remaining gene segments were classified based on these 7 HA study 
clades.  The distribution of the neuraminidase gene segment among IAVs 
circulating in US swine is illustrated in Fig 3d (subtype N1) and Fig 3e (subtype 
N2).  Most of the internal gene segments (1, 2, 5, 6, 7, and 8) clustered also into 
seven monophyletic clades (Fig 4); however eight sequences from these gene 
segments (highlighted with an asterisk in Figs 3 and 4) did not cluster within the 
expected phylogenetic clade. Additionally, there were eight monophyletic clades 
for PA gene (segment 3) because IAVs in HA SC7 had two different PA lineages 
(Fig 4c, named 7a and 7b). These genome differences allowed us to identify 12 
reassorted IAVs (Fig 5) during the study period.  Reassorted IAVs were found in 
farms 2, 3, and 5 and in the three pig subpopulations studied.  
 
Viruses with HAs clustering in study clades 1, 2, 3, 4, and 7 had matrix genes 
(segment 7) of pandemic origin (Fig 4e), while viruses with HAs clustering within 
study clades 5 and 6 had matrix genes of non-pandemic origin (Fig 4f). 
Furthermore, 79% (n=98) of the matrix gene sequences (segment 7) from our 
study contained a signature mutation (S31N) that has been associated with 
resistance to the antiviral amantadine (138). In contrast, viruses with HAs 
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clustering in clades SC3 and SC7 had non-structural genes (segment 8) of 
pandemic origin (Fig 4g) while the remaining viruses carried non-structural genes 
of non-pandemic origin (Fig 4h).  
 
To better understand the within farm diversity of IAVs in pig breeding herds, the 
pairwise percent nucleotide identity (ClustalX alignments) was estimated for each 
segment sequenced during the study period. Detailed results for HA and NA 
comparisons are shown in Fig 6. Nucleotide sequence identity for PB2, PB1, PA, 
HA subtype H3, NP, NA subtypes N1 and N2, and NS segments was higher than 
90%. However, the minimum pairwise percent identity for segments HA subtype 
H1 and M were 74.7% and 86.9%, respectively. Furthermore, the temporal 
distribution of IAVs by clade, farm, and pig-subpopulation is shown in Fig 7 and 
illustrates the emergence, persistence and subsidence of different HA lineages 
over time. At the subpopulation, level only piglets and new gilts harbored IAVs 
from more than one HA study clade at a given sampling visit. IAVs clustering 
within three different HA study clades were isolated from piglets and new gilts in 
farm 3 at month 1 and 10 respectively, and from piglets in farm 2 at month 9. 
Moreover, IAVs from study clades 2, 3, and 6 were recovered only once over 
time within the same farm while IAVs from study clades 1, 4, 5, and 7 were 
isolated multiple times (Fig 7).  
 
While IAVs from SC1 persisted in multiple farms (farms 1, 3 and 4) IAVs from 
study clades 4, 5, and 7 persisted only in farms 1, 5, and 3, respectively (Fig 7). 
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At the farm level, the minimum HA percentage identity among persistent IAVs 
was 98% and the time of persistence ranged between 35 and 283 days (Fig 8). 
Moreover, IAVs from study clades 1 and 7 persisted simultaneously in farm 3 
(Fig 7). Initially, IAVs from study clades 1, 3 and 7 were co-circulating in piglets at 
month 1 in farm 3; then, IAV from SC3 were not isolated again, and only study 
clade 1 and 7 viruses were recovered at a later point from gilts at month 4, and 
from new gilts at months 5, 9, and 10. 
 
To expand our understanding on the molecular diversity of IAVs in pig breeding 
herds we translated the HA and NA genetic sequences into hypothetical protein 
sequences and compared them. We stripped the polymorphic amino acid sites 
from the HA and NA hypothetical-proteins alignment and compared them among 
HA study clades (Fig 9).  The number of polymorphic amino acid sites among HA 
study clades in the HA1 region ranged between 1 and 15 (Fig 9a). No 
polymorphic amino acids were found within the HA2 region of HA and only three 
polymorphic sites were found within the signal peptide region (C12Y, in 
sequences from clade 5; Q17L, in sequences from clade 6; and S8N in 
sequences from study clade 7). Only one site in HA proteins from study clade 5 
(amino acid 503) had 3 polymorphic amino acids at these positions (E, D and N) 
while all other sites had only 2 polymorphic amino acids. Finally, the number of 
polymorphic sites among NAs ranged between 1 and 29 (Fig 9b) and only one 
site in NA proteins from viruses in SC7 (amino acid 370) had 3 polymorphic 





To evaluate the epidemiology and genetic diversity of IAVs in pig breeding herds 
over time, we conducted a one-year longitudinal study and characterized the 
complete genome of 123 virus isolates recovered from three pig subpopulations 
in 5 Midwestern pig breeding herds from the USA. Our results showed evidence 
of emergence, maintenance and subsidence of different viral genotypes over 
time. Furthermore, we revealed the dynamic nature of co-circulating IAV 
genotypes within farms and the on-going exposure of pigs to different antigenic 
subtypes and antigenic viral variants within subtypes. Our findings illustrated the 
complexity of IAV genetic diversity within breeding herds and among pig sub-
populations and provide a better background for IAV control in pig breeding 
herds.  
 
Understanding IAV evolution in endemically infected pig-populations is complex 
due to the molecular characteristics of the virus and the high turnover rates of the 
host. In our study, multiple IAVs co-existed at the herd level in one or multiple pig 
subpopulations. However, some IAV genetic lineages persisted over time while 
others appeared to “subside” or disappear.  The persistence of IAVs in pig farms 
has been reported before (17) and facilitates virus drift over time. Nevertheless, 
the extent of genetic analysis performed in this study provided information on 
genetic and antigenic diversity of IAVs in endemically infected breeding herds to 
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a level that has not been previously available as well as a more accurate 
characterization of the dynamics of IAV diversity within swine herds. Our IAV 
isolates included genotypes that were closely related to each other (e.g. viruses 
clustering within the same phylogenetic clade) and viruses that were clearly 
distinct (e.g. different IAV subtypes) and illustrated the dynamic makeup of IAV 
genome in pig breeding herds.  
 
The ecological circumstances that allow IAVs to persist or disappear in swine 
populations are still not clearly determined. The simplest explanation for this 
dynamic occurrence of IAVs in swine populations is the antigenic diversity of the 
virus. IAVs can drift over time avoiding immune responses against divergent 
IAVs (41, 62, 82). At the HA level, swine IAVs with different genetic lineages are 
known to have different antigenic properties (76, 139). Furthermore, in pigs with 
or without passive immunity to IAVs, HA nucleotide mutations can happen rapidly 
after infection (140). However, IAVs are transmitted with a collection of HA1 
alleles (sequence variants) that can emerge or disappear during infection of 
naïve or immune pigs (73). This dynamic transmission of different IAV alleles 
during infection of vaccinated pigs involves the entire genome of the virus and 
not only HA (141), which suggest that the emergence, maintenance and 
subsidence of certain IAV genotypes over time at the population level might start 
with varying virus replication rates at the individual level specifically due to 
varying host immune responses (82, 142, 143).  
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In this study we focused on those pig subpopulations with the highest turnover 
rates in pig breeding herds because these subpopulations are expected to have 
different ages and diverse immune statuses. In mice, different immune status 
(naïve vs. vaccinated) has been associated with antigenic drift of IAVs (63) 
although one study comparing naïve and vaccinated pigs did not find differences 
in the genetic diversity of IAVs between groups during infection (73). While the 
antibody repertoire of piglets (3 weeks or younger) is mostly maternally derived; 
in gilts and new gilts this repertoire depends basically on previous exposures to 
IAV antigens. Hence, future studies addressing the diversity of maternally 
derived immunity in piglets before weaning and its effect on IAV diversity and 
evolution are required.  
 
Moreover, in the USA there are almost 70 million commercial pigs, which include 
around 6 million sows. Every year, gilts replace 45 to 55% of the sow population 
and each sow gives birth and weans 27 and 24 piglets respectively (25). 
Therefore, in a herd of 1000 sows, 500 new gilts are introduced every year (~48 
every 5 weeks), and 450 piglets are born every week replacing one third of the 
piglet population. We speculate that the high turnover rate of piglets and the 
continuous introduction of gilts into breeding herds are significant factors 
associated with IAV diversity, the introduction of novel IAVs into pig breeding 
herds, and the emergence of reassortant IAVs. 
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The co-circulation of two or more IAVs allows genetic reassortment and the 
emergence of novel IAVs (23, 144). In North America, the genetic diversity of 
swine IAVs has increased dramatically since the emergence of the triple 
reassortant internal gene (TRIG) cassette in 1998 (16, 75) and the introduction of 
several human IAVs into swine populations, including the 2009 pandemic virus 
(15, 61). In this study we found several reassortant viruses, which included 
reassortment events with viruses isolated in this study (suggestive of 
reassortment happening during the study period), and reassortment events with 
viruses not isolated in this study.  Whether the reassorted viruses identified in 
this study emerged within the herds studied, in the herds that supplied the gilts, 
or in other pig herds is not clear. However, in this study the isolation of three 
IAVs with more than 8 gene segments (mixed genotypes) indicated that the 
conditions for reassortment to occur existed during the study period. In contrast, 
the identification of gene segments that were closer to other IAVs not isolated in 
this study, but currently circulating in the USA, suggest that external sources 
(e.g. other pigs) are also important for the emergence of reassortant viruses in 
breeding herds. Therefore, we believe that in pig breeding herds, the 
interventions to control IAV infection should not only target the transmission 
within herds, but also minimize the risk of new IAV introductions.  
 
The ability of IAVs to exchange gene segments over time not only increases the 
mechanisms of virus diversification but also may allow genetic traits (e.g 
signature mutations) to move between IAVs. Seventy-nine percent of IAVs 
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isolated in our study contained a signature mutation (S31N) in the matrix gene 
(segment 7) that might confer resistance to amantadine (138). This high 
prevalence of amantadine resistance is in agreement with two previous studies 
on swine IAVs (145, 146). Interestingly, amantadine is not FDA labeled for use in 
pigs in the USA. Moreover, the incidence of human IAVs resistant to 
adamantanes changed from 0.4% in 1994 (147) to 15.5% in 2006 (148) and 
could be associated with antiviral usage in humans.  Whether the high frequency 
of S31N in the matrix gene among swine IAVs is due to a random events, as 
indicated by Baranovich et al., 2015 (145), or due to reassortment events, as 
indicated by Krumbholz et al., 2009 (146) is not clear and must be further 
investigated. Nevertheless, multiple introductions of human IAVs into swine 
populations have led to the establishment of certain IAV gene lineages (61) and 
we speculate that in that process, genetic resistance signatures to antivirals, 
such as amantadine, have also been incorporated. Hence, these introductions 
and establishment of “foreigner” IAV gene segments into swine populations could 
likely result in unique, for example drug-resistant, genotypes.  
 
Our results do not represent the overall dynamic of IAV infections in pig breeding 
herds in the Midwestern USA given our herd-selection bias. Additionally, we 
could have missed some IAVs over time given our study design and prior 
genotype selection by culturing the viruses rather than sequencing it directly from 
the swabs. Our sample size did not allow us to explore further the association 
between the genetic diversity of IAVs and pig sub-populations (e.g. we cannot 
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test which subpopulation had more or less IAV diversity). Moreover, we could not 
identify the source or directionality of transmission of the IAVs in these herds. 
Given that new gilts are introduced in to the farm from external sources, we 
believe that they are the most likely source of the introduction of genetically 
distinct IAVs, although air (20) and fomites (19) can also represent a risk for new 
IAV infections in pig herds. Alternatively, gilts could have also become infected 
with resident viruses after arrival. Future studies sampling gilts at arrival to 
breeding herds could clarify the relative importance of gilts as a source of new 
IAVs to the breeding herd versus their role in amplifying resident viruses. 
Moreover, caution should be taken when using our estimates for the linear 
association between the distance-to-the-root of the phylogenetic tree and time (in 
days) for each genetic lineage analyzed in this study. The observations used 
(sequences) are not independent from each other because the virus is evolving 
from a common ancestor (149) hence, the assumption of independence is 
violated. We acknowledge that there are other methods (e.g Bayesian analysis) 
to estimate evolutionary rates and TMRCA. Nevertheless, our results are 
comparable to studies using Bayesian analysis to study swine IAVs (61) and 
FastTree2 has been confirmed as a robust method for phylogenetic studies of 
large datasets (135). 
 
In conclusion, our study demonstrates the complex and dynamic occurrence and 
maintenance of IAV infections in pig breeding herds. Complete genome 
amplification and NGS technologies allowed us to characterize with more 
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precision the complete genome of IAVs over time. We showed that IAVs can be 
sustained for prolonged periods of time and that distinct IAVs can co-exist within 
and between subpopulations in these herds. Thus, pigs in breeding herds are 
repeatedly exposed to distinct IAVs over time. Our results also indicated that pig 
population dynamics and not only the viral mechanisms of genetic diversification 
should be taken into account in elucidating the diversity and evolution of swine 
IAVs. We speculate that if transmission of IAVs is reduced in the breeding herds 
the distribution of IAVs to other pig sites after weaning will be minimized. Hence, 
understanding the epidemiology and evolution of IAVs in pig breeding herds will 
allow us to design more effective strategies to reduce the impact of IAV infections 






Table 6. Total number of nasal swabs collected, samples positive to influenza A virus (IAV) by reverse real time 
polymerase chain reaction (RRT- PCR), and IAV isolates distributed by farm, subpopulation and subtype.  
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Table 7. Simple linear regression estimates for the association between the distance-to-the-root of the 
phylogenetic tree for each gene segment dataset and time (in days).  
Thirteen different genetic lineages of swine influenza A virus gene segments (datasets) were used. January 1st 2003 was 
set as day 1 and the best fitting root for each tree was estimated using Path-O-Gen v1.4. 
 
+ Influenza Research Database (IRD) and United States Department of Agriculture (USDA). 
++ β1 is expressed as number of nucleotide difference between sequences for each day increment over time 
between January 1st 2003 and October 16th 2014.  
+++ Estimated time to most recent common ancestor (TMRCA).  
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Figure 3. Phylogenetic relationships between antigenic gene segments of 
influenza A virus (IAV) isolates from this study and IAVs circulating in the 
USA between January 1st 2003 and October 16th 2014. 
Panels a, b and c represent hemagglutinin (HA) sequences and panels d and e 
represent neuraminidase (NA) sequences. The HA sequences under analysis 
clustered into 7 distinct study clades (SC): 1 (blue); 2 (purple); 3 (pink); 4 (lime); 
5 (green); 6 (turquoise); and 7 (aqua). Neuraminidase (NA) sequences are 
colored according to HA study clades and the asterisk “*” indicates one N2 




















Figure 4. Phylogenetic relationships of the internal gene segments of influenza A virus (IAV) isolates from this 
study and IAVs circulating in the USA between January 1st 2003 and October 16th 2014.  
 
Tree leaves representing sequences from this study are colored according to the hemagglutinin (HA) study clades (SC1 – 
SC7) illustrated in Fig 3 and asterisks “*” indicate sequences that did not cluster within the expected clade. 
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Figure 5. Reassortant influenza A viruses (IAVs) found during the study 
period. 
The genome constellations for 12 IAVs are shown distributed by farm, 
subpopulation and month. Gene segments are color-coded based on HA study 
clades: 1 (blue), 2 (purple), 3 (pink), 4 (lime), 5 (green), 6 (turquoise), and 7 
(aqua). Gray indicates sequences that were closer to other IAVs not isolated in 














Figure 6. Hemagglutinin and neuraminidase sequence comparison within 
and between farms.  
Dendrograms and heat maps illustrate the pairwise identity matrix (ClustalX 
alignment) for hemagglutinin (subtypes H1 and H3) and neuraminidase 
(subtypes N1 and N2) sequences. The color key and histogram for the pairwise 
identity comparison is indicated top left side in each panel. The side color bar in 
each dendrogram indicates the farm number for each sequence as follows, farm 
1 (aqua), 2 (purple), 3 (blue), 4 (olive), and 5 (green). Additionally, the distribution 
























Figure 7. Influenza A virus (IAV) isolates distributed by hemagglutinin (HA) 
study clades (SC1-SC7), farm (F1-F5), subpopulation (new gilts (NG), gilts 
(GL) and piglets (PG)) and month. 
Each column represents a sampling month and rows indicate farm and pig 
subpopulation. Within farm, each box represents a sampling event and missing 
boxes indicate months when samples were not collected. White boxes indicate 
sampling events when IAV was not isolated. Bars within boxes indicate IAV 
isolation and are color-coded according to HA phylogenetic study clades SC1 to 


















Figure 8. Dendrograms and heat maps illustrating the pairwise identity 
matrix (ClustalX alignment) between hemagglutinin sequences of the same 
study clade (SC) identified within the same farm over time. 
 
a) Farm 1 subtype H1 SC1, b) Farm 1 subtype H3 SC4, c) Farm 3 subtype H1 
SC1, d) Farm 3 subtype H3 SC7, e) Farm 4 subtype H1 SC1, f) Farm 5 subtype 
H3 SC5. The side color bar in each dendrogram indicates the month when each 





Figure 9. Percentage of polymorphic amino acid sites in the hemagglutinin 
(panel a) and neuraminidase (panel b) of influenza A virus (IAV) isolates. 
IAV subtype, HA study clade, and number of sequences used in each 
comparison is indicated. The polymorphic site indicates the most frequent amino 
acid found (first letter), the position (number) and the variant amino acid (second 
letter). Horizontal bars represent the percentage distribution of each amino acid 
at each polymorphic site. (*) Indicates polymorphic sites within the signal peptide 
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Influenza A viruses (IAV) carry a segmented negative sense RNA genome that is 
able to reassort with other IAV strains (antigenic shift) and/or evolve by the 
accumulation of mutations throughout the genome (antigenic drift) (9).   Two 
proteins are known as major IAV antigens, hemagglutinin (HA) and 
neuraminidase (NA), and their genotypes are associated to the host species that 
each virus infects (41). Accumulation of mutations and gene exchange between 
IAV during infection is expected to influence viral fitness within and transmission 
between species (43, 150). Factors responsible for mutations in IAV are not 
completely understood; however, a viral non-proofreading polymerase (48), 
immune selection (151), and intra-host characteristics are known to play key 
roles (5, 73, 126).  Although wild waterfowl are considered the natural reservoirs 
for IAV, pigs can be intermediate hosts(49) with a propensity for generating 
reassortant viruses(13) and sustaining infections that result in new viruses of risk 
to other species, including humans (152).  
 
Herd prevalence estimates indicate that IAV infections are endemic and 
widespread in pigs (120). In the US, after the emergence of the 2009 pandemic 
H1N1 (pH1N1) in swine, the HA gene of H1 subtype clustered in 5 different 
phylogenetic groups (α, β, γ, δ1, and δ2) which illustrates the broad diversity of 
IAV in pigs (56).  Active surveillance in U.S. swine has shown that 90% of the 
herds surveyed throughout a two-year period tested virus positive for IAV (17). 
Furthermore, these herds were positive for multiple IAV strains of a variety of 
subtypes resulting from several reassortment events (23).  Such IAV diversity in 
pigs increases the challenges faced in both understanding IAV evolution and 
controlling IAV in pigs.  
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Suckling pigs serve as an important source of IAV since they can be 
asymptomatically infected and can transport the virus to multiple geographical 
locations at weaning.  Virus shedding occurs even if passive (38) or active 
immunity (64) are present, and different genotypes of IAV can co-circulate in 
swine populations regardless of their immune status (73) which may result in the 
emergence of novel reassortant strains. However, little is known about genetic 
diversity and selective evolution of IAV in suckling piglets with passive immunity. 
Given the central role that suckling pigs play in the dissemination and emergence 
of IAV strains in pig farms, the objective of this study was to evaluate the degree 
of antigenic drift in the HA of a H1N1 virus in pigs with passive immunity under 
experimental conditions.    
 
Materials and Methods  
 
Study design and sample selection: 
 
An IAV negative swine herd was selected for the study. The herd was considered 
negative for IAV based on serology (NP ELISA, IDEXX, Ref) and clinical history. 
Sows were either vaccinated with an experimental vaccine (PASSIV-VAC) 
prepared with H1N1 influenza virus A/Swine/IL/02450/08 (α cluster, NCBI 
accession number: CY099052.1) or left unvaccinated (NAIVE). The vaccine was 
an adjuvant inactivated vaccine and administered intramuscularly at 5 and 2 
weeks prior to farrowing.  
 
At weaning, 30 and 39 piglets were selected from the PASSIV-VAC and NAIVE 
groups respectively and moved to the University of Minnesota animal isolation 
units. Nine pigs from the NAIVE group were randomly selected to be used as 
seeder pigs, and were infected intra-nasally and intra-tracheally with 0.5 ml of an 
inoculum containing 10-7 TCID50  of influenza A/Swine/IA/00239/04 H1N1 virus 
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(β cluster, NCBI accession number: EU139832.1). The remaining pigs were 
randomly allocated into groups of 10 pigs (3 replicates per group).  
 
Sows in the PASSIV-VAC group were confirmed not to have been exposed to 
IAV before vaccination by testing serum samples by ELISA assay (FlockChek® 
Avian Influenza MultiS-Screen Antibody Test Kit, IDEXX Laboratories Inc., 
Westbrook, ME, USA). Piglets in the NAIVE group were also confirmed to not 
have immunity to IAV via serum sample tests using the same ELISA assay. 
Additionally all piglets in the PASSIV-VAC and NAIVE were confirmed to be IAV 
negative prior to exposure to the seeder pig by testing nasal swabs by RRT-PCR 
(85). 
 
After pigs were exposed to at least one seeder pig, nasal swabs were collected 
daily for 14 days and tested by RRT-PCR targeting the matrix gene (M)(85). The 
seeder pigs remained with the rest of the pigs throughout the study. For 
sequencing purposes, one positive sample from each animal was conveniently 
selected based on the lowest cycle threshold (CT) value obtained on the matrix 
RRT-PCR reaction and all infection days were represented. Full HA gene 
amplification was performed directly from the selected nasal swabs. Blood 
samples were collected prior to infection and at the termination of the study. All 
sera were assayed by hemmaglutination inhibition (HI) test (90) against the 
challenge virus, A/Swine/IA/00239/04, and the vaccine virus, 
A/Swine/IL/02450/08.  
 
Sequencing and sequence analysis: 
 
In order to establish virus HA genetic and protein relatedness between the 
challenge and vaccine virus, full length HA sequences of A/Swine/IA/00239/04 
(EU139832.1) and A/Swine/IL/02450/08 (CY099052.1) were first aligned and 
compared using Clustal W (MegAlign, LaserGene Core 9. DNASTAR).     
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From each selected sample, HA gene was amplified using previously described 
primers (93), and PCR products confirmed by electrophoresis in 2% agarose gel 
and stained with ethidium bromide. The expected band for HA (1780 base pairs) 
was excised from the gel and eluted using QIAquick Gel Extraction Kit (QIAGEN) 
following manufacturers’ recommendations, and submitted to the Biomedical 
Genome Center (BMGC) of the University of Minnesota for sequencing using a 
primer walking scheme.  
 
The trace files obtained from each sample were assembled using the HA 
sequence of A/swine/New Jersey/11/76(H1N1) as a reference. The template was 
then removed and the consensus sequence for each sample established. All 
contigs were initially assembled using the default parameters of SeqManPro 
(LaserGene Core 9, DNA-STAR) and the quality of each nucleotide trace was 
evaluated visually in each position. Only nucleotide calls with clear peaks were 
considered for analysis. Each trace file was trimmed when peaks were 
considered ambiguous to obtain complete sequences with good quality reads.  
Each consensus sequence was annotated using the influenza annotation tool of 
the NCBI (http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/annotation.cgi), 
and trimmed accordingly to obtain the HA coding region.  
  
Complete sequences within each group were aligned and compared by Clustal 
W (MegAlign, LaserGene Core 9. DNA-STAR) using the consensus from all 
sequences as reference, nucleotide differences were classified as either 
transitions (purine↔purine or pyrimidine↔pyrimidine) or transversions 
(purine↔pyrimidine) according to the base pair interchange identified, and their 
phylogenetic distance was compared using a median-joining network algorithm 
(153). The proportion of synonymous (SM) and non-synonymous (NSM) 
mutations were assessed and compared between groups. In some cases, full-
length HA sequences were not obtained, thus short reads for those samples 





The nucleotide substitution mean was obtained for each group (sum of the 
number of nucleotides substituted/total number of nucleotides sequenced in all 
samples) and compared between groups using a one-tail t-test. Results were 
considered statistically significant at p<0.05. Additionally the odds of non-
synonymous mutations (NSM/SM) were compared between groups using only 
complete HA sequences. Finally the frequency of non-synonymous mutations 
present more than once was compared between groups (including complete and 
incomplete sequences). For these last two comparisons tabular methods were 
used and considered statistically different when χ2 p < 0.05. If the count per cell 
in each comparison was lower than 5 then a Fisher-exact test was used.    
 
HA protein models: 
 
To better visualize the location of the amino acid differences identified, the 
structure of the translated HA1 regions were modeled using A/Swine/Iowa/15/30 
(H1N1) as template (PDB:1RUY) with the tools offered in swissmodel.expasy.org 
(154). Each amino acid substitution detected was mapped within the predicted 
model for the reference sequence and its location compared with the five 
antigenic sites previously identified for A/PR/8/1934 (PDB: 1RU7) (155, 156) 
using PyMOL™ 2010. The nucleotide numbering for HA followed the numbering 
for the entire HA gene, while the amino acid numbering was segregated by 
sig_peptide, HA1 and HA2 portions, such that each region of the molecule was 




The number of days that pigs tested positive, and the PCR positive samples 
selected for sequencing and comparison are shown in Table 8. Prior to exposure 
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all pigs in the NAIVE group tested negative to IAV by ELISA (S/N ratio ≥0.673) 
and all pigs in the PASSIV-VAC group tested positive (mean: 0.254, min: 0.09, 
max: 0.495). HI titers for each group before and after contact to the seeder pig 
are shown in Table 9. HI titers against the challenge strain increased in both 
groups after infection.  
 
HA gene sequence of A/Swine/IA/00239/04 and A/Swine/IL/02450/08 aligned 
within the β and α H1 clusters of swine IAV, respectively, and both followed the 
same reading frame described for the human pandemic influenza virus 
A/California/04/2009(H1N1) (GenBank: FJ966082.1). The overall nucleotide and 
amino acid identity for the HA gene and hypothetical proteins, as well as the 
identity for each expected antigenic site are summarized in Table 10.    
 
Both SM and NSM were observed in both groups of pigs (Table 11). Differences 
were observed within sig-peptide and HA1 region for the NAIVE group (16 
complete sequences), and within HA1 and HA2 for the PASSIV-VAC group (9 
complete sequences). Additionally 12 and 16 partial sequences were obtained in 
the PASSIV-VAC and NAIVE groups respectively, and their polymorphisms are 
summarized in Table 12. The total number of polymorphisms identified in both 
groups led to eight different HA alleles (complete sequences different one from 
each other), and their phylogenetic relatedness is illustrated in Fig 10. 
  
The nucleotide substitution mean for the NAIVE (2.94 x 10-4) was lower 
(p=0.042) when compared to the mean in the PASSIV-VAC group (6.4 x 10-4).  
The odds of NSM in the PASSIV-VAC group was 1.29 times higher compared to 
the NAIVE group (Table 13), however this difference was not statistically 
significant (p>0.05). Overall, the most common non-synonymous mutation in both 
groups was at position 515 and the odds of this mutation (G515A) in the 
PASSIV-VAC group was 1.6 times higher compared to the NAIVE group (Table 
14), however this was not statistically different (p=0.38). Table 15 summarizes 
the hypothetical amino acid substitutions found in all groups and Fig 11 shows 
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their location within the HA1 protein model. All changes in the NAIVE group were 
mapped within antigenic site B, while changes in the PASSIV-VAC group were 
located within antigenic site A, B, and D. The substitution identified at position 
155 found in both groups, indicate a change from a polar to a charged amino 
acid, all the other substitutions found in the PASSIV-VAC group did not change 
the amino chemical nature, but the substitution found in the NAIVE at position 




IAV in pigs represents a constant risk to other species including humans since 
pigs serve as a reservoir for IAV that can result in zoonotic infections of 
pandemic proportions (10). Although it is known that factors such as active 
immunity can play a role at inducing IAV change, little is known about the degree 
of virus diversity found in pigs with passive immunity. In this study, we evaluated 
genetic and antigenic changes in the HA of an H1N1 IAV in pigs with and without 
passive immunity under experimental conditions with emphasis on changes 
observed in young pigs early in the infection process. Although nucleotide 
substitution in swine IAV is believed to be lower compared to human viruses (60), 
this study demonstrates that genetic changes can occur in young pigs early 
during infection and those changes can induce amino acid changes located 
within antigenic sites. Furthermore, both SM and NSM were observed in the HA 
protein of pigs with and without passive immunity, and sequences from both 
groups are genetically related regardless of immune status. Even though the 
nucleotide substitution mean was higher in the PASSIV-VAC group compared to 
the NAIVE group, the odds of NSM in the PASSIV-VAC group was not 
significantly higher compared to the NAIVE group. Changes in the chemical 
nature, especially of G155E identified in 11 pigs (5 and 6 in the NAIVE and 
PASSIV-VAC respectively), indicate that there might be specific changes that 
occur in early infection to improve viral fitness in a new host. However, the 
biological significance of this type of change as it relates to immune pressure 
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needs to be further investigated.  The dynamic distribution of IAV subtypes in 
pigs, and the ability of the virus to change early in infection has been described 
and suggests that allele fixation can occur rapidly (73).  
 
Immune pressure and vaccination have been associated with virus change in 
other animal models (63).  In swine, the use of influenza vaccines is common 
and usually vaccines are administered to breeding females prior to farrowing. 
According to USDA National Animal Health Monitoring System (NAHMS) data, 
70% of large breeding herds (> 500 sows) in the US vaccinate against IAV 
(http://www.aphis.usda.gov/animal_health/nahms/swine/downloads/swine2006/S
wine2006_is_vacc.pdf). Pre-farrowing vaccination is practiced to enable transfer 
of passive immunity and minimize clinical disease to progeny. However, passive 
immunity is generally insufficient to prevent transmission of IAV in pigs (38). It is 
logical that immune pressure created by vaccination of pigs would drive virus 
change.  However, in our study, passive immunity did not affect virus 
transmission and we did not see significant genetic differences between immune 
and naïve pigs. The similarity of virus change between groups in this study could 
also be a result of the phenotypic differences between the virus used to prepare 
the vaccine and the virus used to infect the seeder pig. However these results 
are in agreement with a recent study where it was shown that vaccination did not 
appear to have a major effect on the genetic structure of intra-host viral 
populations through immune selection (73).  
 
We selected samples based on the amount of genetic material present in the 
sample and ensured that there was representation of infection through all days of 
the study. Most of the mutations were observed one time post infection. Only one 
mutation was seen in multiple animals. This mutation was at position 155 of HA1 
and it was observed in naïve and immune pigs. This mutation resulted in glycine 
to glutamate substitution, which changes the predicted conformation of the HA 
structure. Substitution at this same site was also described by Hensley et al., 
2009, but only in immune mice after serial passages. Furthermore the mutation, 
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E156K of (63) A/Puerto Rico/8/34(H1N1), which aligns with 155 of 
A/Swine/IA/00239/04 in this study, was mapped within HA antigenic site B and 
was associated to immune escape. Additionally a mutation at position 155 was 
also described by Kuroda et al., 2010 (157) as a likely rare event in a human 
sample from a 33 year old male diagnosed with pandemic influenza virus 
(A/Nagano/RC1/2009(H1N1)) (accession number AB538389) who died from 
respiratory failure and multiple organ dysfunction syndrome. In the present study, 
the mutation at position 155 seemed to be common and was not associated with 
immune status or increase in clinical signs (results not shown). It is possible that 
this mutation was present in the inoculum virus in low frequency, but that it was 
replicated more efficiently taking over the most predominant allele identified in 
the challenge virus. Alternatively, the mutation may have happened in one or 
several seeder pigs, and then transmitted to the study pigs. This mutation may 
have provided the virus some advantage when transmitting from the 
experimentally infected seeder pig to the new hosts but this was outside the 
scope of this study. Furthermore, none of the other mutations identified were 
common to both groups.  
 
It is important to highlight in this study that despite the reduced sample size, 
changes in antigenic sites were not restricted to pigs with immunity indicating that 
antigenic drift in pigs can happen early during the infection-transmission chain 
and may be driven independently from immune selection. This must be further 
investigated given the risk of swine IAV to human health and the impact of IAV 
on pigs health. Although most of the amino acid changes were observed in 
antigenic sites of the HA protein considered to be under higher selection 
pressure, there were changes also observed in the two other regions of HA that 
stabilize the conformation of the HA protein, the signal peptide and HA2. The 
biological implications of these substitutions are not known and further studies 
are needed to characterize their role in pathogenicity and viral fitness. However 
this suggests that amino acid changes outside the antigenic sites may also be 
important for the virus to adapt and transmit to new hosts.  
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In summary this study shows that antigenic drift of IAV can happen in young pigs 
shortly after infection. Overall, pigs with passive immunity had more nucleotide 
substitutions compared to naïve pigs. However, in this study these changes did 
not always result in phenotypic changes in the HA protein that resulted in new 
antigenic variants. Nevertheless, this study is important in order to highlight the 
role of the suckling pig as a potential source of IAV genetic diversity in pigs. This 
is especially important given that extensive movement of suckling pigs takes 
place after weaning in the swine industry. In addition, nucleotide substitutions 
that induce amino acid changes were detected in naïve animals as well as in pigs 
with passive immunity. Some of these changes were able to persist throughout 
the infection period. Furthermore, changes were also identified in non-antigenic 
sites indicating that viral adaptation during transmission in pigs is not only 
dependent on its antigenic characteristics. Overall this study indicates the 
complexity of genetic diversity in pigs and further studies are needed to 
understand viral evolution and epidemiology of IAV in swine populations and the 
















Table 8. Tables indicate the pigs in the PASSIV-VAC and NAIVE groups.  
Numbers in the top indicate the days post contact (DPC) for each group. Grey 
boxes indicate the samples that tested positive by RRT-PCR for IAV, and the 
numbers within the gray boxes indicate the CT value of the samples that were 
used for HA sequencing.  The days where all pigs tested negative were excluded 




    
Table 9. Reciprocal geometric mean HI titers against A/Swine/IA/00239/04 




Table 10. Hemagglutinin nucleotide and amino acid identity between 





nt: Nucleotide sequence 
a.a: Amino acid sequence 
* Note that antigenic sites are not linear. Each position for each antigenic site 
previously described was compared between sequences used in this study. 
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Table 11. Summary of nucleotide substitutions found in the full length HA 




1Number of full lengths HA sequences 
2 Type of substitution compared to the reference sequence.  
3 Base pair substitution effect on the hypothetical translated protein (SM: 
synonymous mutation, NSM: non- synonymous mutation) 
4 Reference nucleotide according to reference sequence 
5 Position based HA numbering 
6 Variant nucleotide 
7 HA region where the substitution was found 
8 Frequency: number of times the specific difference was observed 
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Table 12. Nucleotide reads in partial sequences at positions where 




1Number of partial HA sequences obtained 
2 Reference nucleotide according to reference sequence 
3 Position based on the full length of the HA sequence 
4 Nucleotide read at the indicated position 
5 Frequency: number of times the specified read was found  
 
Table 13.  Non-synonymous (NSM) versus synonymous (SM) mutations in 




Odds of NSM in the PASSIV-VAC = 9/1 = 9 
Odds of NSM in the NAIVE= 7/1 = 7 
OR =   1.29 (Fisher’s exact test p>0.05)  
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Odds of NSM at position 515 in the PASSIV-VAC = 10/14 = 0.714 
Odds of NSM at position 515 in the NAIVE= 8/18 = 0.444 
OR= 1.61 (p=0.38) 
 





1Numbering for each hypothetical protein 
2NA:  No applicable (Synonymous mutation)  
3Ref: Amino acid predicted in the reference sequence 
4Var: Amino acid predicted in the variant sequence   
5Site: Antigenic site where the substitution was mapped 
6Frequency: number of times the specific difference was observed 





Figure 10. Network analysis of the different alleles identified among all 
samples.  
Each circle represents a different allele and its size is proportional to the number 
of sequences by allele identified (Total number of sequences included in the 
analysis = 25). Yellow and blue indicate the sequences from the NAIVE and 
PASSIV-VAC groups respectively. The numbers indicate the position were 







Figure 11. Protein model for one HA1 monomer of A/Swine/IA/00239/04 
(challenge virus).  
(a) Mesh model highlighting the spatial distribution within the protein of the amino 
acid that were found different. Close ups b, c and d, represent the predicted 
surface of the protein and the area exposed for each amino acid replaced. 
NAIVE: Q189P (magenta) within antigenic site B; PASSIV-VAC: K171R (red) 
within antigenic site D and A135P (yellow) within antigenic site A. The green 
spheres represent G155E that was seen in both groups NAIVE and PASSIV-
















Chapter 5: Genome plasticity of triple reassortant H1N1 
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Influenza A viruses (IAVs) are distributed globally and can infect a wide range of 
host species including humans (158), birds (2), pigs (16), horses (126), dogs (5), 
cats (6) and seals (159). Wild waterfowl are considered the natural IAV reservoir 
(9) and a genetically distinct lineage of viruses has also been identified in bats 
(8). A swine origin H1N1 IAV was responsible for the first pandemic of the 21st 
century (10)  and was associated with over 200,000 human deaths (160). In 
recent decades, the genetic diversity of swine IAVs in North America has 
increased significantly due to the emergence of triple reassortant H3N2 viruses in 
the late 1990s (54), the numerous introductions of human-origin viruses in pigs 
including the 2009 pandemic virus (15), and the large-scale movement of pigs 
between different US regions (13).  It is estimated that over 90% of swine herds 
in the Midwestern US are infected with IAVs (17) and that pigs can be exposed to 
different IAVs during their life time (23, 128).  
 
IAVs belongs to the family Orthomyxoviridae and have a segmented genome 
composed of eight single-stranded negative-sense RNA segments that encode 
for at least 12 proteins: polymerase basic 2 (PB2), polymerase basic 1 (PB1), 
polymerase acid (PA), hemagglutinin (HA), nucleoprotein (NP), neuraminidase 
(NA), matrix (M) and non-structural protein (NS).  RNA viruses have a high 
mutation rate that increases their genetic diversity over time (161-163), and the 
segmented nature of the IAV genome allows the virus to exchange (reassort) 
gene segments with other IAVs contributing to the overall genetic diversity of 
IAVs.  
 
The main antigenic proteins of the virus, HA and NA, determine IAV subtype. In 
pigs H1N1, H1N2 and H3N2 are the most prevalent IAV subtypes (3). In North 
American swine there are six antigenically and phylogenetically distinct H1 
groups (α, β, γ1, γ2, δ1, and δ2) (56, 76), and four H3 groups (I, II, III and IV) 
(54). Multiple IAV subtypes can co-circulate in swine herds and persist at the 
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population level for prolonged periods of time (17, 128). Additionally, multiple 
alleles (sequence variants of the same virus) can co-exist during IAV infection of 
pigs (73) and the same virus can evolve differently in the upper and lower 
respiratory tract of pigs (74). Furthermore, nucleotide substitutions within the HA 
antigenic sites can occur shortly after infection of pigs with no significant 
differences noticed between pigs with or without immunity to the virus (73, 140).   
 
In the US most of the pigs may be exposed to one or more IAVs during their 
lifetime. Hence the majority of pigs may have immunity to one or several IAVs 
strains when they are challenged with currently circulating IAVs. However there 
is a lack of knowledge on how the virus evolves in swine populations that are 
seropositive to different IAVs. Therefore, the objective of this study was to 
explore the genetic diversity of the complete genome of a triple reassortant H1N1 
IAV population during experimental infection of vaccinated pigs. A vaccine with 
multiple IAV strains was used to mimic field conditions where pigs are usually 
exposed to different IAVs. We identified several polymorphisms using next 
generation sequencing (NGS) directly from nasal swabs and reconstructed 13 
complete genomes of the within-host viral populations (metagenomes) using 
polymorphism overlapping sequence fragments analysis demonstrating the 




Animal IAV infection status before and after contact with the seeder pig: To study 
the genomic plasticity of a triple reassortant H1N1 IAV during infection of 
vaccinated pigs we obtained 11 pigs free of IAV, vaccinated 10 and infected 1 to 
serve as seeder. All pigs (n=11) were IAV negative by real time RT-PCR (RRT-
PCR) and seronegative by NP-ELISA prior to vaccination. Two weeks after the 
booster vaccination, and before contact with the seeder pig, nine pigs tested 
ELISA positive to IAV (S/N< 0.6) and 1 was a suspect (S/N=0.803). Three pigs 
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were negative (HI titer < 1:20) and 7 had HI titers < 1:40 to the challenge virus. 
All vaccinated pigs had HI titers > 1:20 to the vaccine viruses (Table 16).  
 
The seeder pig remained negative before challenge and tested IAV positive by 
RRT-PCR 48 hours after challenge.  After introduction of the seeder pig into the 
isolation unit with the remaining pigs (n=10), 5 animals tested IAV positive and 5 
tested negative by RRT-PCR during the study period (Table 17). Prior to the 
introduction of the seeder pig, the mean S/N ELISA titer was not statistically 
different (p=0.75) between pigs that tested positive and negative by RT-PCR. 
However, 14 days after the introduction of the seeder pig the S/N ELISA titer was 
lower (p=0.04) in pigs that tested RT-PCR positive compared to pigs that tested 
RT-PCR negative (Table 16).  Additionally, we also found statistically significant 
differences (p<0.05) in the HI titers before and after contact to the seeder pig, 
between pigs that tested positive and pigs that tested negative by RT-PCR 
(Table 16). 
 
Extensive allelic variation was identified by sequence analysis during infection:  
The complete genome of IAV was amplified and sequenced from 13 samples 
which included the inoculum virus before challenge, two samples from the seeder 
pig at days 2 and 4 (SD2 and SD4) and 2 samples from each of the 5 infected 
pigs after contact (A1D5, A1D7, A2D4, A2D8, A3D5, A3D6, A4D3, A4D6, A5D4, 
and A5D6; where, ‘A’ refers to animal number and ‘D’ refers to day of the study). 
The most frequent allele in the inoculum virus for segments 1, 4, 5, 7, and 8 was 
also the most frequent allele in the pig samples analyzed. In contrast, the most 
frequent allele for segments 2, 3, and 6 was different in pig samples compared to 
the inoculum virus. Many nucleotide polymorphisms (n=794) were found in all 
samples throughout the course of the study and were distributed in all gene 
segments. However, there was great variability in the number of polymorphisms 
between samples and gene segments (Table 18). The overlapping sequence 
fragments analysis estimated a total of 327 alleles of which 214 were unique 
sequences (Table 19).   
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Three of the 41 original polymorphisms present in the inoculum virus were not 
identified in any of the pig samples analyzed and not all alleles in the inoculum 
were identified in the pig samples sequenced. Moreover only 4 emergent alleles 
(defined as alleles not present in the inoculum virus) were found in multiple pigs 
(2 in segment 2, and 1 in segment 3 and 4). Finally, for all but the HA segment, 
the crude ratio of synonymous to non-synonymous substitutions (ds/dn) was 
greater than 1 (Table 19).  
 
Although there was small or no variation in the number of alleles detected 
between the two samples sequenced of most pigs that tested positive, the allele 
frequency changed significantly within animal 1 and 4 (Table 19). We noticed that 
prior to contact to the seeder pig, these two pigs (animal 1 and 4) were negative 
by HI to the challenge virus, and had the lowest HI titer (1:80) to 
A/Swine/Iowa/110600/2000(H1N1), which is the vaccine virus closest to the 
challenge virus at the nucleotide level (Table 16).  
 
HA and NA antigenic proteins diverge independently during infection:  
While forty-four different alleles were found in HA, only three alleles were found 
in NA during this study (Fig 12. The 44 HA alleles identified (Fig 12a), yield 43 
different predicted peptides (Table 20). The starting virus inoculum contained two 
HA alleles that only differed in one nucleotide within the HA2 region. In the 
seeder pig on day 2 (SD2), we found 8 HA alleles (Fig 12a) with variations in the 
amino acid sequence within both the HA1 and HA2 regions (Table 20). However, 
the emergent alleles of the SD2 were not found in any other pig samples 
analyzed. All the other HA emergent alleles were unique to an animal except for 
one that was detected in two pigs (A1D5, A2D8); however, the latter emergent 
variant (A1D5/A2D8, highlighted in Fig 12a and Table 20) contained a HA1 
region identical to the inoculum alleles. Additionally, we found 32 HA alleles in 
A1D7; at the nucleotide level, half of these 32 alleles were closer to an allele 
identified in A4D6 while the other half was closer to an inoculum allele (Fig 12a). 
At the protein level, these 32 variants contained polymorphisms in all three 
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regions of the HA, signal peptide, HA1, and HA2. Overall, amino acid 
substitutions within HA1 were only found in alleles obtained from SD2 and A1D7 
(Table 20); 4 of these substitutions happened within antigen sites previously 
described for HA subtype H1 (Table 20) and their location and nature are 
illustrated in Fig 13.  
 
In contrast, at the NA level only three alleles were found during this study and all 
of them translated the same NA protein. Two of these alleles were present in the 
starting inoculum virus. The majority inoculum allele was not detected in most 
samples sequenced (except in A1D7), and the minority allele became fixed in 
most of the pig samples except for A4D6, in which a third emergent NA allele 




To better understand the evolution of IAVs during infection of vaccinated pigs we 
used deep genome sequencing to compare the viral genetic diversity at two 
separate sampling points during infection. We demonstrated that genetic makeup 
of the virus changed in all gene segments as the virus replicated within the group 
of animals, yielding a complex collection of viral genomes with similar and distinct 
variants. The infection produced a population of heterogeneous alleles by gene 
segment (usually ≥ 2) that was dynamic over time. Therefore our results indicate 
that the genetic heterogeneity of IAVs during infection of partially immune pigs is 
significant and it might have been underestimated. Under this scenario 
controlling the transmission of IAVs in pigs is challenging because in natural 
conditions a large proportion of pigs have maternal or active immunity to different 
IAVs strains (3, 17), IAVs are endemic in swine populations (16), multiple genetic 
lineages of the virus can co-circulate in pigs (23, 128), and pigs are moved and 
mixed in large batches of animals during their production stage (25, 27).    
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In our study the genetic diversity of IAVs changed dynamically throughout the 
course of infection. Two samples that corresponded to two different pigs (A1D7 
and A4D3) had a higher number of alleles compared to the rest of samples. 
Since we did not sequence all samples from all pigs, and our sample size was 
limited, we cannot be certain that a high number of alleles were not present in all 
pigs at some point during infection. However, our results proved that the diversity 
of IAVs could change within a vaccinated pig throughout the course of infection. 
Interestingly, these two pigs (animal 1 and animal 4), were negative by HI to the 
challenge virus (titer < 1:20) before exposure to the seeder pig, and had the 
lowest HI against A/Swine/Iowa/110600/2000(H1N1) which is the closest vaccine 
virus compared to the challenge virus. These findings suggest that in pigs the 
level of antibodies against IAVs might influence the overall diversity of the virus 
during infection. However, this observation needs to be corroborated in future 
studies in particular, in the context of heterologous vaccination to infection. Most 
vaccines are heterologous to circulating viruses and only provide partial 
protection to infection; therefore the variability in the immune response to IAV 
vaccination may influence virus evolution. Individual host factors such as 
response to social stress, (164), individual host genetics, and animal behavior 
may also affect the immune response to viral infections. In addition, it remains 
unclear to what extent different alleles are selected for or whether rapid changes 
in the viral population are primarily stochastic.  
 
In the samples sequenced in this study, the HA segment was more likely to 
undergo non-synonymous mutations compared to the remaining segments, 
including NA. Only one HA emergent allele was found in more than one pig and 
this allele was identical in the HA1 region to the inoculum virus. In agreement 
with our results, other studies in pigs have shown that nucleotide substitutions 
can happen in the HA segment very early after infection in pigs with immunity to 
IAV, and that allele fixation can happen among infected animals (73, 140). 
However, the time required for these substitutions to become fixed at a 
population level is still unknown. Our results are also consistent with a previous 
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study of the HA1 region of the hemagglutinin indicating that IAVs in pigs are not 
being transmitted as a single genotype but rather as a population of viruses that 
may be closely related to each other (73). However, our results also showed that 
nucleotide substitutions can happen in the signal peptide and the HA2 region of 
the hemagglutinin, which were not evaluated by Murcia et al. 2012. In addition, 
other factors in our study such as the group housing conditions, which facilitated 
greater interaction between pigs, compared to previous studies where pairs of 
individuals were used to measure intra-host diversity of IAV (63, 73, 126), may 
have had an effect on the increased overall genetic diversity.  
 
In contrast, we did not find non-synonymous mutations in NA and there was 
therefore no evidence of coevolution of the HA and NA or epistatic interactions. 
Although the dominant NA allele in the inoculum was not observed among the 
majority of samples sequenced, including the seeder, the allele was observed in 
sample A1D7, indicating that it had likely persisted at low levels during 
transmission. This genotype “recovery” has been described for other RNA 
viruses during replication such as polioviruses (165). It is possible that unique 
alleles found in pigs were present in the inoculum at a low prevalence, and that 
we were not able to identify them in the inoculum itself. Additionally, unique 
alleles could have been present in the pig samples that were not sequenced.  
 
Multiple studies have evaluated the intra-host diversity of RNA viruses over time 
(166-168). In IAVs, this research has focused on HA (4, 5, 126). To our 
knowledge, our study is the first approach to study the intra-host diversity of the 
complete genome of IAV during infection of pigs using next generation 
sequencing (NGS) and our results are comparable to a recent study in children 
(169). We uncovered an additional layer of complexity in the evolution of IAVs 
during infection of immune pigs by demonstrating that all IAV gene segments 
replicate as a population of alleles that may or may not be transmitted. Although 
our methods were not able to capture reassortment events within hosts, the intra-
host diversity observed here certainly provides opportunity for novel reassortant 
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viruses to emerge. In other species, the evaluation of intra-host reassortment of 
IAV has shown that two viruses that are closely related to each other reassort at 
different rates depending on their co-infecting dose (170). Genome reassortment 
should be further investigated since it is a potential source of genetic diversity to 
swine IAV. It is not clear to what extent the diversity observed in our study is 
deleterious and not likely to be transmitted onward over longer time periods in 
pigs. Further understanding of the intra-host dynamics of co-infection and 
reassortment remains an important outstanding question in IAV evolution.  
 
The dynamic nature of polymorphisms found in our study highlights that IAV 
genetic diversity ought to be studied directly in the original biological sample (i.e. 
nasal swab). The study of genetic diversity and evolution of IAV populations 
through cell culture might be misleading.  The cell culture of IAV leads to loss of 
diversity as cell culture selects for the fastest growing virus in a new 
environment. As an example, the frequently used MDCK and VERO cell lines 
have differential preferences for IAV variants, which has led to selective rescue 
of specific alleles during serial passages (171). As IAV diversity and population 
dynamics is complex and shaped by many factors including viral fitness, mutation 
rate, host factors, and stochastic events that may produce bottlenecks, a better 
estimate of IAV diversity at the population level can be obtained directly from the 
original sample. However, amplifying the complete genome from IAV isolates, 
where the viral concentration is exponentially higher than the original sample, 
might be easier for certain studies.  
 
It is important to mention different external sources of potential variation and bias 
including sequencing (172), depth of coverage (106), PCR (98, 173) and 
sampling or intra-assay bias or error. The platform we used, 454, is mature and 
errors due to sequencing are considered non-issues since we avoid reads with a 
Phil’s Read Editor (Phred) score <20, polymorphisms in homonucleotide runs, 
not represented in both strands, and not represented in unique independent 
sequence runs (98, 174).  The High Confidence Difference file (HCDiff) that we 
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used takes these three precautions into account.  The 454 has proven to 
accurately detect human immunodeficiency virus mutants at a prevalence as low 
as 0.1% (99).  Nevertheless, the variability on NGS reads mapped and depth of 
coverage throughout the complete genome of IAVs remains an issue to better 
estimate the genetic diversity of the viral populations (106, 175). Additionally, 
PCR  (especially when the polymerase is stalled) generates in vitro recombinants 
that inflate and distort the estimates of the number and structure of the true 
alleles (((173), S., Enomoto unpublished data).  To avoid PCR errors we used a 
high fidelity PCR system that uses a blend of DNA polymerases including one 
isolated from Pyrococcus furiosus (Pfu) which has 3’ to 5’ exonuclease 
(proofreading) activity, with a tenfold improved error rate compared to TaqDNA 
polymerase (176, 177). High fidelity polymerases have shown to enhance the 
PCR and sequencing conditions (178, 179) improving the accuracy to estimate 
microbial diversity.  
 
In conclusion, the swine influenza A viral population in an experimental setting 
was complex. Although we recognize our sampling bias to estimate the complete 
genetic composition of the viral population during transmission, our findings 
demonstrate that the diversity of IAV can change dynamically during infection of 
vaccinated pigs. New sequencing technologies and bioinformatics algorithms 
might provide more precise estimates in future studies.  In this study, the 
polymorphisms were abundant, dynamic and not limited to HA and NA. Some 
variants were maintained while others were not identified among the samples 
sequenced. Direct sampling and deep sequencing allowed us to investigate the 
dynamic plasticity of IAV population during IAV infection in a small group of pigs.  
We envision that the plasticity of IAV’s genome under field conditions is not less 
complex since different IAV subtypes can coexist and susceptible animals are 
continuously introduced into infected populations. Our study emphasizes the 
need to study IAV evolution directly from the infected host using new generation 
sequencing approaches, which will help design better strategies to control 
influenza in animals and people.  More studies are needed in order to evaluate 
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whether the changes observed in this study are due to vaccination or whether 
they are also found in non-immune pigs.   
 
Materials and methods 
 
Study Design:  
 
Eleven 3-week old specific pathogen free (SPF) piglets, were selected from a 
serologically IAV negative swine herd and moved to the University of Minnesota 
animal research units. The IAV negative status was confirmed by testing 
individual nasal swabs with real time RT-PCR (RRT-PCR) targeting the M gene 
(84, 85) and serum samples by ELISA (Influenza Ab Test Kit, IDEXX 
Laboratories Inc., Westbrook, ME, USA) for antibodies against the NP (89).  
 
Viral RNA was eluted using 50 µl of each sample into 50 µl elution buffer using 
MagMaxTM virus RNA isolation kit (Ambion®, USA). AgPath-IDTM One-Step RT-
PCR reagent kit (Ambion®, Life technologies, USA) was used to detect IAV. PCR 
mix containing 5 µl RNA, 12.5 µl 2X buffer, 1.0 µl 25X enzyme mix, 1.67 µl 
detection enhancer, 5 pmol of each primer and 1.5 pmol of probe was run on a 
LightCycler® 480 system (Hoffmann-La Roche, Switzerland) at 45°C for 10 min, 
followed by 95°C for 10 min, and 45 cycles at 94°C for 1 sec and 60°C for 30 
sec. Fluorescence was recorded at 60°C and a sample was considered positive if 
the cycle threshold (CT) was lower than 40. This PCR protocol can detect IAVs in 
samples containing 200 copies or more of the target amplicon, and has a 100% 
and 95% diagnostic sensitivity and specificity respectively (84).  
 
Ten pigs were vaccinated a day after arrival and two weeks later with 2 ml of a 
licensed inactivated trivalent IAV vaccine (FluSure ®, Zoetis Animal Health, New 
Jersey, USA), containing the δ and γ clusters of H1N1 
((A/Swine/NorthCarolina/031/2005(H1N1) and 
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A/Swine/Iowa/110600/2000(H1N1) respectively)) and one H3N2 
(A/Swine/Missouri/069/2005(H3N2)). Two weeks after the second vaccination, 
nasal swabs and blood samples were collected from all pigs and tested for IAV 
by RRT-PCR (85) and ELISA respectively. Additionally, blood samples were 
tested by hemagglutinin inhibition tests (HI) against the challenge and vaccine 
viruses before and after infection as previously described (90). The mean ELISA 
and HI titers were compared between vaccinated pigs that tested RT-PCR 
positive or negative during this study and considered statistically significant if the 
p value for the non parametric one-way analysis of variance Kruskal Wallis test 
was lower than 0.05.  
 
One unvaccinated pig was inoculated with IAV in a separate room to serve as a 
seeder pig to infect the other pigs. Two ml of 1X106 TCID50/ml 
A/Swine/IA/00239/2004 H1N1 IAV (GenBank accession: EU139832.1), grown in 
Madin Darby Canine Kidney (MDCK) cells (92) was used to challenge the seeder 
pig intranasally and intratracheally. The A/Swine/IA/00239/2004 H1N1 clusters 
within the β H1 swine IAVs (56). This virus was selected because it has been 
fully characterized, genetically and antigenically (76), and it has been used in 
several pathogenesis (81) and transmission studies (38, 64, 140).  The challenge 
virus was 91.5 and 73.7 % identical at the nucleotide level to the H1 γ and δ 
vaccine virus strains respectively. The infection was confirmed 48 hours later by 
RRT-PCR and the seeder pig was placed in contact with the rest of the pigs. 
Nasal swabs were collected from all pigs daily for 14 days into 1.8 ml viral 
transport media (MEM plus, 2% BSA and 1% penicillin-streptomycin) and an 
aliquot of the transport media was used for RRT-PCR testing. All pigs were 
euthanized on day 14 and all procedures for this study were approved by the 
University of Minnesota Institutional Animal Care and Use Committee (IACUC) 





Sample selection, genome amplification and sequence identification:  
 
To explore the within host variability of IAV during infection, two IAV positive 
samples from each pig were conveniently selected for complete genome 
amplification and sequencing using NGS technologies (Table 17). Samples with 
the lowest cycle threshold (Ct) value and best genome amplification were 
targeted for sequencing.  IAV genome was amplified using a modified protocol of 
Zhou et al., 2009 (103). Briefly, the viral RNA was purified from the swabs using 
QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA, cat: 52904). IAV cDNA 
was created from viral RNA using primer MBtuni12(M), 
ACGCGTGATCAGCRAAAGCAGG, and Superscript III First Strand Synthesis 
SuperMix (Invitrogen™, Grand Island, NY, USA, cat: 18080-400) cDNA was 
amplified in a PCR (5 cycles of 94°C 15s, 45°C 30s, 68°C 180s  and 31 cycles of 
94°C 15s, 57°C 30s, 68°C 180s), consisting of  PicoMax High Fidelity DNA 
Polymerase (Agilent, Santa Clara, CA, USA, cat:600422), MBtuni12M and 
MBtuni13, ACGCGTGATCAGTAGAAACAAGG.  PCR products were verified by 
gel electrophoresis and purified using QIAquick Spin Kit (QIAGEN, Valencia, CA, 
USA, cat: 28106). Purified cDNA from the virus inoculum and 12 pig samples 
(Table 17) were submitted to the Genomics Center at the University of Minnesota 
for library preparation and 454 sequencing (454 GS-FLX ©, Life Sciences, Roche 
Diagnostics Corporation, Basel, Switzerland) as described in detail by 
Ramakrishnan et al., 2009 (180).  
 
The 454 inoculum reads were assembled with Newbler 2.6 (Roche Diagnostics 
Corporation, Basel, Switzerland) using a reference template obtained from 
GenBank (Table 21) and the inoculum consensus sequence was used as the 
reference genome (RG, Table 22) to assemble the 454 reads from each pig 
sample. The polymorphisms present in each sample were extracted from the 
454HCDiff.txt files created during each assembly in Newbler 2.6. This file 
includes only highly confident differences which are defined as variants identified 
in at least 3 unique reads, and present in forward and reverse reads.  
 104 
      
Alleles identification and overlapping reading test: Alleles (sequence variants) 
were defined as complete functional gene segments identified by aligning 
overlapping sequence fragments. The Newbler output, 454HCDiff.txt, is a file of 
sequence alignments surrounding all the high confidence polymorphic loci. A 
RUBY (181) script was written to test the linkage of two adjacent loci by 
enumerating the occurrence of the four sequence combinations, consensus-
consensus, consensus-variant, variant-consensus, and variant-variant. If greater 
than 80% of the sequences occurred only as two sequence combinations, the 
two loci were considered linked. Presence or absence of polymorphisms at each 
locus was encoded as 1 or 0, respectively. The alleles were deduced by linking 
together the adjacent intervals between the two polymorphic loci and its 
functionality verified using the NCBI FLu ANnotation tool (FLAN) (131). 
Additionally, if the distance that separated two polymorphisms was longer than 
the length of the reads obtained, then those two polymorphisms were considered 
not linked.  For example if two adjacent polymorphic loci were linked and 
recovered as 00 and 11, the segment contained two alleles rather than four 
alleles. The raw 454 reads, the alleles sequences obtained and the Ruby scripts 
for overlapping sequence fragments analysis and allele extraction are available 
upon request.  
 
Sequence analysis: To illustrate the phylogenetic relationship between 
sequences, alleles were aligned to the RG using DNA-Alignment and median-
joining networks were estimated using Network (153). Each network was 
annotated with Network Publisher (Fluxus Technology Ltd, Clare, Suffolk, 
England) and Adobe Illustrator CC (Adobe Systems Incorporated, CA, USA). 
Additionally, for the first open reading frame (ORF) we estimated the average 
number of synonymous (dS) and non-synonymous (dN) mutations and their ratio 
(dS/dN) among sequences (182, 183) using the Synonymous and Non-
synonymous Analysis Program available at www.hiv.lanl.gov  (SNAP, Los 
Alamos National Laboratory, Los Alamos, NM, USA).  
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Hemagglutinin and neuraminidase protein analysis:  
 
For HA and NA, hypothetical proteins were inferred from nucleotide sequence, 
aligned using ClustalX (137) and compared. The amino acid differences among 
HA sequences were mapped to the known H1 antigenic sites (155, 156), 
modeled using the tools available at swissmodel.expasy.org (154) and illustrated 
PyMOL Molecular Graphic Systems, Version 1.5.0.4 Schrödinger, LLC, New 
York, NY, USA. The HA1 IAV template used for our protein model was 
A/Swine/Iowa/15/30(H1N1) (Protein Data Bank (PDB) ID:1RUY. This template 
was used because this virus is from swine origin, the HA has been crystallized, 
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Table 16. Influenza A virus (IAV) serology results by ELISA and hemagglutinin inhibition (HI) tests for pigs prior 
to start the study (before vaccination), after vaccination and after infection.  
For simplicity, animals that tested IAV RT-PCR positive after exposure to the seeder pig (n=5) were renamed A1 to A5 
and animals that tested negative were renamed A6 to A10. ELISA results are expressed as sample to negative ratio (S/N) 
and considered positive, suspect or negative when S/N < 0.6, 0.6<S/N<0.9 or S/N>0.9 respectively. HI titers are 
expressed as the reciprocal dilutions and considered positive at >1:20. Pigs 1 to 5 tested positive to IAV by RT-PCR and 
pigs 6 to 10 tested negative. The reciprocal mean titter is compared between pigs that tested RT-PCR positive and 
negative after exposure to the seeder pig and considered statistically significant if the p value for the Kruskal Wallis test 
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*IAV isolates used in the HI test: 
00239: Challenge virus, A/Swine/IA/00239/2004 (H1N1) 
031: Vaccine virus: A/Swine/NorthCarolina/031/2005(H1N1) 
110600: Vaccine virus: A/Swine/Iowa/110600/2000(H1N1) 
M0069: Vaccine virus: A/Swine/Missouri/069/2005(H3N2). 
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Table 17. Real time influenza A virus RT-PCR results and samples selected 
for deep genome sequencing.  
Nasal swabs were collected and tested for 14 DPC (days post contact). No pig 
tested positive after 8 DPC. The seeder pig is identified as S. Results from five 
pigs that did not test positive at any point during this study are not shown. The 
days when pigs tested positive are indicated by “+” (plus sign) and the RRT-PCR 
cycle threshold (Ct) value for each sample is shown. A total of 12 pig samples 
were selected for complete genome sequencing: Seeder pig, day 2 (SD2, dark 
blue) and day 4 (SD4, light blue); animal A1, day 5 (A1D5, dark green) and day 7 
(A1D7, light green), animal A2, day 4 (A2D4, purple) and day 8 (A2D8, light 
purple); animal A3, day 5 (A3D5, brown) and day 6 (A3D6, light brown); animal 
A4, day 3 (A4D3, dark grey), and day 6 (A4D6, light grey); animal A5, day 4 
(A5D4, pink), and day 6 (A5D6, light pink). Sequences obtained from each 
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Table 18. 454 reads assembly statistics by sample indicating the total number of reads mapped, depth of 
coverage and polymorphisms found among samples.  
 
HCDiff: Highly confident differences (considered true polymorphisms). Total among all samples sequences: 794 
HCDiff. %: Percentage of HCDiff found among all differences. 
 
There was no linear association (p>0.05) between the following comparisons: 
 
1. Total mapped and all differences 
2. Total mapped and highly confident differences 
3. Ave. depth and all differences   
4. Ave. depth and all highly confident differences 
 
There was a negative linear association (-0.18, p=0.001) between average map length and highly confident differences. 
However, the average map length only explained 41% of the variability in the confident differences (R2=0.415).  
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Table 19. Number of alleles distributed by sample and gene segment.  
The last column of the table indicates the ratio between synonymous mutations (ds) and non-synonymous mutations (dn) 
for each gene segment. 214 out of 327 alleles found were unique sequences.  
 
N/A: No dn mutations were found in segment 6, hence no ds/dn ratio was estimated
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Table 20. ClustalX alignment of the complete hypothetical HA proteins found by 
sample.  
Only polymorphic sites among alleles identified in this study are shown. Superscripts A, 
B and D indicate the antigenic site where changes in HA1 were observed. The first two 
rows indicate amino acids found in the vaccine viruses at the polymorphic sites 
identified in the samples sequenced. The reference amino acid (RG) for each 
polymorphic position is shown in inoculum allele 1. Non-highlighted proteins are unique 
variants and proteins highlighted with the same color are 100% identical among them. A 
total of 58 functional HA sequences were identified among all samples. These 
sequences represented 44 unique alleles and translated 43 different hypothetical HAs.  
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*Indicate identical proteins within a sample translated from two different alleles.   
NA: Not applicable. (The complete sequence for 
A/Swine/NorthCarolina/031/2005(H1N1) is not available) 
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Table 22. A/swine/Iowa/00239/2004(H1N1) reference genome (RG) used to 
assemble all pig sample reads, and to compare allele sequences found 
during this study.  
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Figure 12. Median joining networks of Hemagglutinin (HA) and 
Neuraminidase (NA) alleles found during experimental IAV infection of 
vaccinated pigs.  
Each circle represents a sequence variant (allele) and each color represents the 
sample where that sequence was found. Red numbers indicate the number of 
nucleotide differences between sequences (not all numbers are included for 
brevity). Within each network, the branch length is proportional to the number of 
differences between alleles. (*) Indicates an emergent HA allele (not present in 
the inoculum virus) that was found in more than one pig. The color code of this 
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Figure 13. Three-dimensional models illustrating the HA1 region of the 
hemagglutinin and the polymorphic amino acids found during the study.  
Polymorphic amino acid (histidine (H), serine (S), asparagine (N), lysine (L), 
proline (P), glutamate (E), leucine (L), arginine (R), and proline (P)) are indicated 
and colored according to their physical properties: polar (red), charged (green) 
and hydrophobic (yellow). a) Reference amino acids at polymorphic sites in HA1 
for A/Swine/IA/00239 (challenge virus) b) amino acids residues predicted from 
the sample sequenced from the seeder pig at day 2 (SD2) c) amino acids 



























Chapter 6: A prospective cohort study and deep genome 
sequencing demonstrate the complexity of infection, re-infection 
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Introduction 
 
Influenza A viruses (IAVs) are Orthomyxoviruses with eight single stranded 
negative sense RNA gene segments namely polymerase B2 (PB2, segment 1), 
polymerase B1 (PB1, segment 2), polymerase A (PA, segment 3), hemagglutinin 
(HA, segment 4), nucleoprotein (NP, segment 5), neuraminidase (NA, segment 
6), matrix (M, segment 7), and non-structural protein (NS, segment 8). The main 
antigenic proteins of IAVs (HA and NA) are used to classify the virus into different 
subtypes and include at least seventeen HAs (H1-H17(8, 45, 123)) and 9 NAs 
(N1-N9 (2, 123)). To date at least 116 HA-NA IAV combinations have been 
isolated from avian species and aquatic birds are considered the natural 
reservoir for most IAVs present in nature (9). IAVs can also infect different 
mammalian species including humans (184) and pigs (107) although few IAV 
subtypes are endemic in these two species. In North America, H1N1, H1N2, and 
H3N2 IAVs are endemic in pigs and cluster in six H1 (α, β, γ1, γ2, δ1, and δ2) 
and four H3 (I, II, III and IV) genetic lineages (54, 55, 76). 
 
Multiple reassortment events and the introduction of human IAVs, including the 
2009 pandemic virus, changed the genetic landscape of swine IAVs in North 
America (16, 54, 75). The international trade of live swine and pig movement 
within the USA are associated with the increased genetic diversity of swine IAVs 
(13, 24). However, the ecological mechanisms that led to the current genetic 
diversity of swine IAVs in North America are not clearly understood. There are 
several reports of distinct IAVs coexisting in pig populations and the same IAV 
subtype can be found within the same population for prolonged periods of time 
(17, 23, 37). Moreover, in pigs the viral genome of IAV can replicate during 
infection as a dynamic “cloud” of genotypes closely related to each other (141) 
illustrating the complexity of IAV genetic evolution during infection of pigs. 
Nevertheless, there is a lack of knowledge regarding the molecular epidemiology 
and genetic diversity of swine IAVs under field conditions, although it is common 
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to find pigs that are exposed to one or more IAVs during their lifetime (114, 120, 
122, 185). 
 
In the USA, the swine industry produces pigs in batches that are typically moved 
between different production sites before harvest (127). Pigs are born in swine 
breeding herds and weaned at approximately 3 weeks of age to a nursery or to a 
wean-to-finish farm where they stay for seven weeks or until market, 
respectively. If pigs are weaned into a nursery farm then they are moved to a 
finishing farm where they stay until harvest. Moreover, pig production flows can 
be managed as continuous or all-in/all-out flows. In a continuous flow, pigs are 
moved in and out of the production unit (e.g. site, farm, building) on a regular 
basis and there are pigs all the time within the unit. In an all-in/all-out flow, a 
batch of pigs is used to fill the unit (room, barn, or site), and no more pigs are 
added until all pigs from the previous batch have left. In both types of pig flows 
pens and crates are cleaned between batches. Nevertheless, under these 
production systems controlling the transmission of IAVs is challenging and 
requires a better understanding of the epidemiology and molecular biology of 
swine influenza, which is a main cause of respiratory disease in pigs. 
Additionally, IAVs containing genes similar to IAVs circulating in North American 
and Asian swine caused the 2009 IAV pandemic (10) after reassorting in an 
unknown host; hence, understanding the epidemiology and molecular evolution 
of swine IAVs is also important to minimize its zoonotic potential.  
 
We hypothesize that there are three possible explanations for the persistence 
and genetic diversity of IAV in pig herds after weaning. First, there may be 
differences between IAVs from the same genetic lineage that enable the virus to 
evade herd immunity over time. Second, weaned pigs may be the source of the 
same IAV lineage and could introduce similar viral variants with each group of 
pigs weaned; and third, new weaned pigs may allow the continuous replication of 
IAVs present in the swine herd. Therefore, the objectives of this study were to 
assess the epidemiological characteristics and molecular traits of IAVs in a large 
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group of naturally infected 3-week old pigs for a prolonged period of time. We 
designed a prospective cohort study with intensive sampling events in pigs after 
weaning and characterize the complete genome of the viral population over time 
under natural conditions of transmission. We found that different IAVs produced 
two overlapping epidemic waves of infection and that the majority of pigs became 
infected and re-infected during the study period. These results are important 
because we proved the complex dynamics of IAV evolution and diversity in pigs 
after weaning and demonstrated the re-infection of pigs with IAVs that are closely 
related to each other. Understanding the epidemiology and molecular diversity of 
IAVs in pigs is important to design effective health interventions that aim to 
reduce the impact of IAVs on swine health and production, and might reduce the 
public health risk associated with swine IAVs.  
 
 
Materials and methods 
 
Protocols and procedures followed throughout the study were approved by the 
University of Minnesota Institutional Animal Care and Use Committee (IACUC 
1207B17281), and the Institutional Biosafety Committee (IBC 1208H18341).  
 
To estimate the patterns of IAV infection in pigs after weaning and characterize 
the genetic diversity of the virus throughout the growing pig period we designed a 
prospective, randomized pig cohort study in a wean-to-finish farm. This farm had 
a single source of weaned pigs and history of IAV infection. Additionally, this farm 
housed pigs from weaning (3 weeks of age) to market (23 to 24 weeks of age) in 
eight different barns, with an all-in/all-out pig flow by barn. The cohort of pigs 
(n=132) was selected from ~2200 pigs that were weaned into a single barn on 
three different days within a week. Pigs in the cohort were randomly selected 
from the first shipment of pigs. A random number was assigned to each pig at 
arrival and the pigs with the lowest random number were selected as the cohort 
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to study. Sample size was estimated to be 95% confident to detect at least one 
IAV positive pig if the prevalence of infection was 2.5% or higher. Each pig in the 
cohort was ear tagged, individually identified and classified as male or female. 
We kept the cohort of pigs comingled among all other pigs in the barn (as 
distributed by the pig farmer after arrival) and collected individual nasal swabs 
(BBL CultureSwab, Becton Dickinson and Company, USA) on a weekly basis for 
15 weeks. Every week after sample collection, swabs were refrigerated and 
transported to the laboratory within 6 hours of collection on the manufacture’s 
transport media and then placed into 1.8 ml sample storing media within 24 
hours of collection (Dulbecco’s Modified Eagle Medium (DMEM), 5% antibiotic-
antimycotic (Gibco, Life Technologies, USA containing 10000 IU/ml of penicillin, 
10000 µg/ml of streptomycin, and 25 µg /ml of Fungizone), and 2% bovine serum 
albumin (BSA) fraction V 7.5% solution (Gibco, Life technologies, USA). Swabs 
in the sample storing media were vortexed for 10 seconds and stored at -80ºC 
until IAV testing.  
 
All nasal swabs were tested individually by reverse transcriptase real time 
polymerase chain reaction (RRT-PCR) for swine IAVs using protocols described 
elsewhere (84, 85). A sample was considered positive if the RRT-PCR cycle 
threshold (Ct) value was 35 or lower. The weekly prevalence rate (number of 
positive cases per week among all pigs tested) and the period prevalence 
(number of pigs that tested positive at least once during the 15-week study 
period) were estimated. The number of prevalent cases was compared between 
weeks and considered statistically significant if the p value for the McNemars test 
was lower than 0.05. Additionally, the weekly incidence density (number of new 
cases per pigs at risk during a week) was estimated and the incidence density 
ratio between males and females compared. The incidence density ratio between 
males and females was considered significant if the test-based 95 % confidence 
interval did not include 1. Additionally, we estimated the number of weeks that 
the same pig tested IAV positive and defined a “re-infection case” as a pig with 
two or more positive samples in non-consecutive weeks.  
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To characterize the genetic diversity of IAV during infection of pigs after weaning 
a set of 92 RT-PCR positive swabs was selected. Sample selection targeted 
those pigs with 2 or more positive swabs during the study period and those 
samples with the lowest Ct value. At least one positive sample per week was 
included. IAV genome was amplified directly from the nasal swab in a single 
reaction using methods previously described (103). Briefly, viral RNA was 
extracted from positive swabs using MagMax Viral RNA isolation kit (Ambion, 
Life Technologies, USA). One step RRT-PCR was performed using SuperScript 
III One-Step RT-PCR System with Platinum Taq DNA Polymerase (Invitrogen, 
Life Technologies, USA). A 100 µl PCR mix was prepared containing 20 µl 
DNase/RNase-Free distilled water (Gibco, USA), 50 µl 2x reaction mix, 2 µl 
SuperScript III RT mix, 2 µl  (10 µM) of each primer (MBtuni12(M): 
ACGCGTGATCAGCRAAAGCAGG and MBtuni13: 
ACGCGTGATCAGTAGAAACAAGG), and 24 µl of RNA template. Gel 
electrophoresis was used to verify visually PCR amplicons. PCR products were 
purified using QIAquick Spin Kit (QIAGEN, USA), and eluted in 20 
DNase/RNase-free distilled water (Gibco, Life Technologies, USA). Samples 
were then submitted to the University of Minnesota Genomics Center (UMGC) for 
library preparation (TruSeq DNA HT sample prep kit, Illumina, USA) and 
sequencing using next generation sequencing (NGS) technologies (MiSeq paired 
end 250 cycles, Illumina, USA). 
 
Sequencing quality control and quality assurance (QC/QA) was first verified with 
FastQC (129) and then Trimmomatic (102) was used to trim low quality reads 
using the pair-end mode of the software. Sequencing assembly was performed 
using Bowtie2 (100) and SAMTools (97) on a reference template containing 6 
IAV internal gene references and 4 antigenic gene references (PB2 
(CY099076.1), PB1 (CY099309.1), PA (CY045233.1), NP (CY009919.1), M 
(DQ150436.1), and NS (CY050162.1), H1 (FJ789832.1), H3 (KC992248.1), N1 
(GU236519.1), N2 (KC866483.1)). If more than one IAV genotype was found 
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during the study then different genome templates, obtained from the samples 
sequenced, were used to re-map the reads of all samples. The proportion of 
Illumina reads that were mapped to each IAV template was estimated by gene 
segment and week. Consensus sequences for each gene segment of IAV were 
trimmed to coding regions and their functionality verified using the NCBI FLu 
Annotation web-service (FLAN (131)). Complete functional sequences from this 
final assembly were used to estimate IAV diversity during the study period. 
Furthermore, complete genomes were called when the eight complete gene 
segments were assembled. Mixed IAV infections were defined as samples where 
two or more complete consensus sequences for the same gene segment were 
obtained after mapping the Illumina reads to multiple IAV genome templates.  
 
The main antigenic gene segments (HA and NA) were analyzed first and the 
antigenic subtype determined. Then, HA sequences were used to classify IAV 
into different viral groups (VG) based on the phylogenetic origins of H1 (gamma 
1, gamma 2, delta 1, delta 2, alpha, or beta (76)) or H3 (clusters I to IV (54)) 
subtypes using the web-based tools available at the Influenza Research 
Database (132). The number of virus variants for each VG was determined and 
the persistence of the same VG at the population level was estimated over time. 
Then all other gene segments were classified based on the HA designated VGs 
and the genome constellation for each sample sequenced was inferred.  
Additionally, each set of IAV gene sequences (gene segments 1 to 8) was 
aligned using ClustalW (137) and the pairwise distance identity was used to 
compare the viral diversity across gene segments using heat maps. Sequencing 
assembly and analysis was done using the resources available at the University 
of Minnesota Supercomputing Institute (MSI). Statistical analysis and heat maps 
were performed using tabular methods and ggplots 2.17.0 in R. 
 
Hypothetical HA and NA proteins were translated and amino acid sequences 
compared using median-joining network analysis (153). First, all protein 
sequences were aligned to the most frequent sequence found during the study 
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period using DNA-Alignment (Fluxus Technology Ltd, Germany). Then, 
polymorphic sites among antigenic proteins were estimated, polymorphic amino 
acids per site inferred and median-joining networks constructed (153). Protein 
networks were drawn and annotated using Network 4.613, Network Publisher 
(Fluxus Technology Ltd, Germany), and Adobe Illustrator CC 2014 18.1.1 (Adobe 
Systems Incorporated, USA).  
 
Finally, the patterns of IAV infection and re-infection were compared among 
those pigs of which we sequenced more than one positive sample during the 
study period. The percent sequence identity of HA at the nucleotide level was 
used to estimate virus divergence within pigs over time and the findings 
compared to the different HA amino acid sequences found during the protein 




A cohort of 132 3-week old pigs (77 males (58.3%) and 55 females (41.7%)) was 
randomly selected from a group of weaned pigs at weaning  (week 0 (W0)) to a 
commercial wean-to-finish-farm. Males and females were housed on the right 
and left side of the barn respectively and pigs of different sex did not have nose-
to-nose contact. Pigs in the cohort were comingled at arrival with the remaining 
weaned pigs in the batch and were followed for 15 weeks (W1 to W15). While no 
selected females died during this study, five males (6.5%) died at weeks 3, 7, 8, 
11 and 14; unfortunately, their cause of death was not determined. A total of 
2,080 individual nasal swabs were collected over 15 weeks and 369 (17.7%) of 
them tested positive for IAVs by RRT-PCR. At weaning (W0), 27 pigs (20.5%) 
tested IAV RRT- PCR positive without a significant difference between males 
(n=17) and females (n=10) (p=0.74). The 15-week period prevalence of IAVs 
infection was 98.4% (n=130). Only two pigs (1.6%) tested IAV negative 
throughout the study period, although one of these pigs died in W3. Moreover, 
116 pigs (87.9%) tested positive to IAV more than once (Fig 14) and 103 pigs 
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(78%) were IAV positive in at least two non-consecutive weeks, hence 
considered re-infected with IAVs. 
 
There were two epidemic waves of IAV infection during the study period (Fig 15) 
with no statistical difference between the number of prevalent cases at the 
epidemic peaks in W2 and W7 (p=0.24). Within 15 weeks, the weekly prevalence 
of IAV infection ranged between 0% and 65.2% (Table 23). The number of IAV 
positive males and females was statistically different only at W1 (p=0.04), W2 
(p=0.004), and W6 (p=0.04). However, given the distribution of pigs within the 
barn (males on the right and females on the left) it was not possible to determine 
if this difference was associated with the pigs’ sex (castrated male or female) or 
their location within the barn (right or left). The incidence density of IAV infection 
of pigs after weaning ranged between 0 and 71 cases per 100 pig-week (Table 
23) and for most of the weeks it was not statistically different between males and 
females. However, at week 6 the incidence density of IAV infection in males was 
3 times higher than in females (p<0.05).  
 
Ninety-two out of 369 positive swabs (25%) were used for IAV genome 
amplification and deep genome sequencing using Illumina as the next-generation 
sequencing (NGS) platform. After the first template-assembly, three different 
influenza A virus groups (VG) were identified (VG1, VG2, and VG3). At the HA 
level VG1, VG2 and VG3 clustered within North American H1-gamma, H1-beta 
and H3-cluster-IV IAVs respectively. At the NA level VG1 and VG2 were N1 
viruses while VG3 were N2 viruses. The pairwise percent identity (ClustalW) 
between the consensus sequences of all gene segments of three representative 
samples (n=24) of the three VGs is shown in Table 24. These 24 templates were 
used to re-assemble all samples sequenced. After quality control and quality 
assurance, nine samples (10.8%) yielded only partial IAV gene contigs and were 
excluded from the analysis. From the remaining samples (n=83), 13,559,009 
Illumina sequencing reads were successfully mapped to the reference templates 
(Fig 16). Overall, the majority of Illumina reads obtained from the first epidemic 
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wave of IAV infection mapped to the reference templates of VG1 (H1 gamma 
virus) while the majority of reads obtained after week 6 mapped to the reference 
templates of VG3 (H3 cluster IV virus). However, in most weeks we detected 
reads that mapped to at least two different VGs. Illumina reads mapping to the 
reference templates of VG2 only predominated in samples sequenced in W4 and 
W14 (Fig 16). The sequencing assembling process yielded 649 complete IAV 
sequences, from 83 pig nasal. These 649 sequences were classified based on 
the sequence template mapped (Table 25) as VG1 (n=402, 61.9%), VG2 (n=19, 
2.9%), and VG3 (n=228, 35.1%). There were no complete IAV gene segments 
obtained from W9 to W13 and W15.  
 
We found different genome constellations among all samples sequenced  (Fig 
17) and different VGs co-circulating over time. While we recovered complete 
gene sequences from a single VG at W0, W3 and W5, we recovered complete 
gene sequences from two different VG at W1, W4 and W8, and from all three 
VGs at W2, W6 and W7. Moreover, 53 samples (63.8%) contained eight 
complete IAV gene segments, 13 (15.7%) contained more than eight and 17 
samples (20.5%) contained less than 8 gene segments. Furthermore, 70 
samples (84.3%) contained only sequences from a single IAV VG although 13 
(15.7%) had gene segments from more than one VG (VG1 and VG2, n=1; VG1 
and VG3, n=10; or VG1, VG2, and VG3, n=2). Additionally, six samples 
contained two different IAV antigenic subtypes (H1 gamma plus H1 beta, n=1; H1 
gamma plus H3 cluster IV, n=2; and N1 plus N2, n=5 (Fig 17)).  
 
Out of all complete IAV gene segments obtained (n=649), 78 (12%) and 83 
(12.7%) were HA and NA sequences, respectively. The HA and NA pairwise 
sequence identity is illustrated in Fig 18. HA VG1 (subtype H1 gamma) 
sequences (n=48) were assembled between W0 and W7 and their percent 
sequence identity ranged between 98.2 and 100%. In contrast, HA VG2 (subtype 
H1 beta) sequences were only assembled at W4 and W14 and were 100% 
identical. Additionally, HA VG3 (subtype H3 cluster IV) sequences were identified 
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only between W6 and W8 and their percent sequence identity ranged between 
99.9% and 100%. Moreover, NA sequences (n=83) included 50 sequences from 
VG1 (subtype N1), two from VG2 (subtype N1) and 31 from VG3 (subtype N2). 
NA sequences from VG1 were found between W0 and W7 while NA sequences 
from VG3 were assembled only at W1, W6, W7 and W8. The pairwise percent 
identity among NA sequences ranged between 99.6% and 100% for VG1 and 
between 98.8 % and 100% for VG3. In contrast, NA sequences from VG2 (n=2) 
were only assembled from W4 and W14 and were 100% identical. The 
consensus sequences of each internal gene segment (genes 1,2,3,5,7 and 8) 
were aligned using ClustalW and also showed a clear distinction between VG1, 
VG2, and VG3 for all internal gene segments (Fig 19).  Within VGs (VG1, VG2 or 
VG3) the lowest percent identity among all gene segments was observed for 
gene segment 7 (matrix) and 8 (non-structural) (Fig 19e and 19f respectively).  
 
The hypothetical HA and NA proteins for VG1, VG2 and VG3 were deduced to 
visualize differences within viral groups. For VG2, the two HA and NA sequences 
were 100% identical; thus, no further protein predictions were performed. In 
contrast, VG1 and VG3 had different HA and NA sequences, and some variants 
circulated more frequently than others (Fig 20). Nine different HA and nine NA 
amino acid sequences were translated from VG1 (Fig 20a and 20b respectively). 
Of 48 HA proteins from VG1, the majority (n=36) corresponded to two specific 
amino acid sequences, visualized in Fig 20a as node 1 (n=21) and node 2 
(n=15); sequences represented in these two nodes differed by a single amino 
acid (T287A) and circulated until W6. The additional HA sequences (n=6) from 
VG1 were variants of the two major nodes. Only one HA variant was present at 
W0 for VG1 (Fig 20a) while three different NA proteins were found (Fig 20b). 
However, only the sequence represented in NA node one was identified in more 
than two weeks. Furthermore, six additional NA variants were identified after W0, 
but only those represented in nodes four and eight were identified from more 
than one sampling week (Fig 20b).   
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In contrast, only four different HA and four NA proteins were translated from VG3 
(Fig 20c and 20d respectively). The most frequent HA proteins (node 1) from 
VG3 was first identified at W6 and persisted until W8 while the other three HA 
proteins were only identified at W7 and W8 (Fig 20c).  The first NA protein from 
VG3 was identified at W1 and was not recovered again throughout the study 
period (Fig 20d). Furthermore, the most frequent NA variant of VG3 was 
identified at W6 and proceeded for two additional weeks while the remaining two 
variants were found only at W7 (Fig 20d).  
 
To understand IAV infection and re-infection in pigs after weaning we compared 
the nucleotide and amino acid HA sequences of those samples sequenced from 
the same pig over time. Fifty-six samples collected from 26 pigs were used for 
this analysis (Fig 21). Five out of these 26 pigs (19.2%) had IAVs from the same 
VG (VG1 or VG3) and the HA pairwise nucleotide sequence identity within pig 
ranged between 98.2% and 100%. Additionally, 23 out of these 26 pigs (88.5%) 
met our definition of re-infected pigs (tested IAV positive in two non consecutive 
weeks). Complete HA sequences representing VG1 and VG3 were assembled 
from pig 41 at W6 and W7 (Fig 21); therefore, animal 41 was also considered a 
re-infected case for the sequencing analysis. Most IAV re-infections (19 out of 
24, 79.2%) happened with IAVs from different VGs (VG1 and VG3, n=18; and 
VG1 and VG2, n=1). However, in five re-infected pigs (20.8%) the same VG 
(VG1) was recovered and the percent of sequence identity within pig for these 
viruses ranged between 99.6 and 99.9%. Moreover, when we compared the 
hypothetical amino acid sequences within pigs, we found that 2 out of 5 pigs 
(40%) infected with IAV in consecutive weeks had HA sequences that differ in 1 
or 10 amino acids respectively while the other 3 pigs (60%) had the same HA 
protein (100% identical). In contrast, all 5 pigs re-infected with the same VG had 
HA proteins that were different in 1 or 2 amino acids (Fig 21).   
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Discussion 
 
To understand the long-term persistence of influenza A viruses (IAVs) in pigs 
after weaning we designed a prospective cohort study and followed 132 3-week 
old pigs for 15 weeks after weaning. Using molecular detection, deep genome 
sequencing and hypothetical predictions of the main antigenic proteins of IAVs 
we demonstrated the complexity of IAV epidemiology and molecular diversity 
during infection of pigs under field conditions. These findings are important 
because they contribute to the understanding of persistence of IAVs in swine 
populations and should help us design better health interventions to prevent and 
control the disease in pigs. Additionally, prospective cohort studies in pigs could 
serve as an excellent animal model to study IAV transmission and evolution in 
humans, or to test the efficacy of health interventions given the physiological and 
immunological similarities between humans and pigs (186), the homology 
between human and swine IAVs, and the similarity on IAV transmission among 
humans and pigs (1, 24, 76).  
 
We found that at the population level the persistence of IAV infection was the 
result of two contiguous IAV epidemics in which three distinct viral groups (VGs) 
co-circulated. Each epidemic wave of IAV infection was dominated by VG1 and 
VG3 respectively. However, VG1 and VG3 were both found co-circulating 
throughout the study period. Furthermore, a third virus group (VG2) was found 
co-circulating with VG1 and VG3 without dominating in any of the epidemic 
waves identified. Hence we determined that the endemic infection of IAV in this 
population was due to multiple VG causing contiguous epidemic waves. A similar 
epidemic trend of swine IAV infection has been described before in pigs after 
weaning in Europe (187) and might explain why swine populations are 
continuously infected with IAVs (17, 37, 128). In the Midwestern USA, 90% of 
pig-production herds (with growing pigs) are considered positive to IAVs (17) and 
in Europe swine IAVs are also widely distributed in  pig farms (18). To our 
knowledge this is the first prospective cohort study that evaluated in detail the 
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complete genome of IAVs during transmission under field conditions and 
demonstrated that at the population level swine IAVs are also transmitted over 
time as a “cloud” of genotypes that are either closely related to each other or 
clearly distinct (different subtypes).  
 
The co-circulation of different IAV alleles (sequence variants) during infection of 
children (169), horses (126), pigs (73, 141), and dogs (5) has been demonstrated 
before. The plasticity of swine IAV at the individual level (73, 141) might translate 
into our findings at the population level. This plasticity of the IAV genome over 
time may play a key role in the continuous outbreaks of IAVs and IAV re-infection 
of pigs after weaning. RNA viruses have higher mutation rates compared to 
many other microorganisms in nature (44, 188). Hence, finding a “cloud” of IAVs 
closely related to each other at the population level was expected. However, our 
findings unraveled a deeper layer of IAV diversity during infection of pigs 
because they demonstrated that this “cloud” of genotypes (virus groups) could 
exist concurrently for different VGs changing dynamically over time.  
 
It is unclear in this study why the different VGs presented themselves at different 
times throughout the study. Different IAVs are expected to circulate in pigs after 
weaning (17, 18). However, different IAVs replicate at different rates under 
different environments (70, 71, 171, 175), which can affect viral fitness and 
transmission rates (189). For example in pigs, maternally derived antibodies (38) 
and acquired immunity (64) affect the transmission rates of IAVs among weaned 
piglets. If two different IAVs are transmitted at different rates then the proportion 
of IAVs found over time could change as observed in this study. The effect of 
virus fitness, transmission rates, and host immunity on IAV diversity over time 
should be further investigated and could highlight the targets for future effective 
health intervention methods.  
 
Moreover, we found the complete genome of VG2 (100% identical) at W4 and 
W14 and strong evidence of VG2 co-circulating with VG1 and VG3 at other 
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sampling weeks. This finding indicated that some IAV genotypes might hiddenly 
replicate underneath the overall cloud of IAV genotypes and could only be 
recovered when the epidemic of the dominant VGs have ended. A recent study in 
North America illustrated how new genetic lineages of swine IAVs have emerged 
without being noticed for several years (76) while others that were commonly 
found before (e.g. H1 beta IAVs) now circulate unnoticed (75, 76). Therefore we 
speculate that the diversity and evolution of swine IAVs might be greatly 
underestimated or biased towards those genotypes that are over-represented 
during IAV epidemics or that are selected by procedures of virus culture (171). 
Our approach to evaluate the complete genome of IAVs directly from the nasal 
swab samples using NGS technologies should provide a greater resolution of 
IAV variants circulating in pig populations during infection and should help 
provide a better representation of the viruses that are circulating.   
 
In this study we found two epidemic waves of IAV infection that overlapped at 
some point between W3 and W6 and could have allowed different VG to 
exchange gene segments. However most samples contained consensus genome 
constellations that represented a single VG although several samples contained 
gene segments from different IAVs. The segmented genome of IAV allows two or 
more viruses to exchange gene segments during infection (genetic reassortment) 
(9, 41) which is an important mechanism of virus diversification and emergence 
of novel IAV with zoonotic (11, 144) and pandemic potential (10). In pigs the 
antigenic genes are swapped between IAVs at different rates (72) and indicates 
that IAV reassortment in pigs is not a random event. However it is not know in 
what phase of IAV epidemics reassortment happens. If a single VG is dominating 
an epidemic reassortment might be less likely to happen. However, if two 
epidemics overlap reassortment might take place. In other species, the frequency 
of genetic reassortment among IAVs closely related to each other is random (70) 
while viruses evolving from very distinct genetic lineages are more restrictive 
(71). Therefore, further investigation is required to understand swine IAV 
reassortment events since this mechanism of virus diversification has changed 
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the genetic makeup of the virus during the past three decades (16, 54) and 
allowed the emergence of the first human pandemic of the 21st century (53).  
 
It is assumed that most pigs at weaning would have some sort of MDA to 
different IAVs. Hence it is expected the HA and NA will be under higher immune 
pressure during infection after weaning compared to other viral gene segments 
because HA and NA are the main antigenic proteins of the virus. However, the 
highest genetic diversity within IAV gene segments from the same VG was found 
for gene segment seven (matrix) and eight (non-structural) and not for segments 
four (HA) and six (NA). Furthermore, the distance matrix for the percent pairwise 
sequence identity of all IAV gene segments allowed us to differentiate the same 
IAV viral groups. One previous study showed that all IAV gene segments, and 
not only HA and NA, present a dynamic distribution during infection of pigs with 
immunity to different IAVs (141). Another study, demonstrated that the 
substitution rate for HA1 was not different between pigs with or without active 
immunity to IAVs (73). Although, immune selection could depend on the affinity 
of antibodies to a given virus, IAV antigenic selection due to existing immunity is 
poorly understood and should be further investigated, especially to understand 
IAV immune evasion and re-infection in pigs after weaning. 
 
During this cohort study, most cases of IAV re-infection happened with IAV 
containing different antigenic subtypes (H1N1 and H3N2), which is expected 
given the antigenic differences between H1 and H3 IAVs. However, in this study 
re-infection also happened with viruses that differed at the HA level in only one or 
two amino acids. Whether these amino acid differences changed or not the 
antigenic properties of the virus allowing IAV re-infection to happen needs to be 
further investigated in future studies. IAV re-infections have been described and 
characterized in humans (190-192). In pigs the mechanisms that allow IAVs to 
re-infect an animal are not clearly defined and need further investigation. Multiple 
factors have been proposed to explain IAV re-infection which include host, 
environment and virological factors (193) such as antigenic drift (63), differences 
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in cross protection among IAVs phenotypes (38, 194), immune response (142, 
190), maternally derived immunity (143, 195) and the competition between naïve 
and memory B cells (196). One single amino acid difference within HA can 
change the antigenicity and receptor binding avidity of IAVs in humans and other 
animal species (63, 197, 198) and several polymorphic amino acid sites have 
been associated with antigenic differences among swine H1 viruses (56, 76), and 
6 to 7 amino acid sites appear to be very important among swine and human H3 
IAVs (197, 199).  
 
This study also provides additional information in regards to epidemiological 
findings relevant to what happens within swine populations. The number of 
prevalent cases between each epidemic peak of IAV infection at week 2 (W2) 
and 7 (W7) respectively was not statistically different suggesting that the 
threshold point at which swine IAV epidemics subside was similar and that the 
transmission pattern of two different IAVs (VG1 and VG3) within the same 
population followed the same trend. This information is valuable because if 
transmission patterns of IAV infection in pigs are predictable then health 
interventions could be design to prevent them. Moreover, the prevalence and 
incidence density of IAV was different between males and females at some 
weeks after weaning. Unfortunately, males and females were housed in two 
different sides of the barn (right and left side respectively) and were separated by 
a hallway that did not allow nose-to-nose contact between pigs of different sex. 
Therefore, it was not possible to differentiate if these statistical differences were 
associated to the pigs’ sex or their location within the pig barn. The association 
between influenza A virus and sex is not clear in humans (200). While some 
studies have shown that there are differences in viral infection patterns between 
males and females not associated to specific behaviors (200, 201), others have 
shown that hospitalization rates in children associated with respiratory infections 
can be different between males and females (202). However there is no 
information available regarding this issue in swine populations. Nevertheless, if 
sex is not likely to be associated with swine IAV infection then our results 
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indicated that some pens were more likely to test positive than others over time, 
which could be an indication of how the virus was transmitting between pens 
during the study period.  
 
We recognize the limitations of our study design. Our results might only 
represent the population of pigs from which the cohort was selected. However, 
the pig farm selected for this study represented a common commercial wean-to-
finish farm in the USA and the epidemiological findings of this study are similar to 
prior studies in the USA (17, 37), Europe (187),  and field reports by veterinarians 
in the USA. Additionally, our random sample selection and large sample size 
minimized the random error and allowed us to make conclusions at the 
population level. Moreover, the detection of IAV by RRT-PCR might not 
represent true infections, as it cannot differentiate the stage of IAV infection or 
whether replicating virus was present, which needs to be taken into consideration 
for all data interpretation. Additionally, it is possible that the estimated genetic 
diversity of IAVs during this study is biased because we only selected a set of 
positive samples. However, we sequenced 25% of all positive samples and 
performed the genome amplification directly from nasal swabs, which avoided 
genotype selection during IAV isolation. The number of samples tested and 
sequenced in this study is probably the largest in any cohort study done to date 
in pigs after weaning.   
 
In conclusion we demonstrated the complexity of IAV infection and re-infection in 
pigs after weaning in a large population of pigs under field conditions. We 
illustrated the dynamic diversity of the complete genome of IAVs over time and 
characterized its effect on the main antigenic proteins of the virus (HA) and (NA). 
The prolonged persistence of IAVs in pigs after weaning can be the result of 
multiple IAV epidemics that take place repeatedly over time or the re-infection 
with IAVs that are closely related to each other. These findings are important for 
decision making to control IAVs in pigs after weaning and to better understand 
virus diversity and emergence of IAVs in endemically infected swine populations. 
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Table 23. Epidemiological findings.  
Number of pigs that tested influenza A virus (IAV) positive by real time reverse transcriptase polymerase chain reaction 
(RRT-PCR) distributed by week (W) and sex. Prevalent and incident cases (incidence density) are shown by week and 
compared between males and females.  
 
* Males and females were located on the right and left side of the barn respectively 
**Indicate significant difference (p<0.05) between males and females. 
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Table 24. Pairwise sequence comparison among influenza A virus gene 
templates.  
Percent identity (ClustalW alignment) between gene segments of three 
representative influenza A viruses from virus group 1 (VG1, H1 gamma), 2 (VG2, 
H1 beta), and 3 (VG3, H3 cluster IV) that were used to map all Illumina 
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Table 25. Frequency distribution of complete influenza A virus sequences by virus group (VG1, H1 gamma; VG2, 
H1 beta; and VG3, H3 cluster IV) and gene segment.  
Polymerase base 2 (PB2), polymerase B1 (PB1), polymerase A (PA), hemagglutinin (HA), neuraminidase (NA), matrix 
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Figure 14. Number of pigs and sampling times that pigs tested positive to 
influenza A viruses.  
Each bar represents the number of pigs with 0 to 6 IAV positive swabs during the 
study period.  
 
Figure 15. Prevalent and incident cases of influenza A virus distributed by 
week.  
Green bars represent the total number of RRT-PCR positive cases per week 
(prevalent cases) and yellow bars illustrate the number of new cases found every 
week (incident cases).  
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Figure 16. Distribution of Illumina sequencing reads for each gene segment 
over time.  
Percentage of illumina sequencing reads mapped to influenza A virus gene 
segments (1 to 8) distributed by sample, week and viral groups one (VG1), two 
(VG2), and three (VG3). Each bar represents a sample. The y-axis indicates the 
percentage of reads by sample that were mapped to VG1 (H1 gamma, blue), 
VG2 (H1-beta, yellow) and VG3 (H3-cluster-IV, green) templates. The x-axis 
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Figure 17. Influenza A virus (IAV) gene constellations distributed by week 
and sample.  
The first four columns indicate the week (W0 to W14), number of samples 
sequenced (n=83), number of complete IAV gene segments per sample, and 
total number of sequences obtained. The remaining columns indicate IAV gene 
segments assembled based on viral group one (VG1, blue), two (VG2, yellow), 
and three (VG3, green). White boxes indicate that it was not possible to 
assemble a complete IAV gene segment. 
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Figure 18. Hemagglutinin (HA) and neuraminidase (NA) pairwise sequence 
identity.  
Each heat map illustrates the percent sequence identity (ClustalW) among HA 
(a) and NA (b) sequences. The color key and histogram (x axis: percent identity; 
y axis: count) for each distance matrix is illustrated at the top left of each plot. 
Pairwise comparisons among virus group one (VG1, H1 gamma), two (VG2, H1 
beta) and three (VG3, H3 cluster IV) are highlighted within black boxes. 
Dendrograms are distance based and illustrate the phylogenetic relationships 
between sequences. The bar side color at the left of each heat map indicates the 
sampling week (week 0 (W0) to week 14 (W14)) for each sample. The HA and 
NA pairwise comparison within and between groups is shown at the bottom of 
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Figure 19. Pairwise sequence identity (ClustalW) among influenza A virus 
(IAV) internal genes.  
The color key and histogram (x axis: percent identity; y axis: count) for each 
distance matrix is illustrated at the top left of each plot. Pairwise comparisons 
among virus group one (VG1), two (VG2), and three (VG3) are highlighted within 
black boxes. Dendrograms are distance based and illustrate the phylogenetic 
relationships between sequences. The bar side color at the left of each heat map 
indicates the sampling week for each sample (week 0 (W0) to week 14 (W14)). 
The pairwise comparison within and between virus groups is shown at the bottom 




















  147 
Figure 20. Network analysis of hemagglutinin (HA) and neuraminidase (NA) 
protein sequences of virus group one (VG1, H1 gamma) and three (VG3, H3 
cluster IV).  
Network plots represent the relationships among HA and NA protein sequences 
for VG1 (panels a and b) and VG3 (panels c and d). Each node (circles) 
represents a protein sequence and its size is proportional to the number of 
sequences per node. Red numbers indicate the node number and sequence 
frequency (n) per node. Furthermore, nodes are color-coded according to 
sampling weeks (W0 to W8). The distance between nodes is proportional to the 
number of amino acid differences between sequences (larger distances are 
indicated as “-//-“ to fit the plot) and polymorphic sites (position and amino acid 
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Figure 21. Patterns of influenza A virus (IAV) infection and re-infection.  
Fifty-six hemagglutinin (HA) nucleotide sequences obtained from 26 pigs over 
time (week 0 to week 15) are illustrated based on virus group one (VG1, H1 
gamma blue), two (VG2, H1 beta yellow), and three (VG3, H3 cluster IV green).  
Three different patterns of IAVs are shown: 1) HA sequences from the same IAV 
group found within a pig in consecutive weeks; 2) HA sequences from the same 
IAV group found within a pig in non-consecutive weeks; and 3) HA sequences 
from different IAVs found within a pig in consecutive or non-consecutive weeks. 
White numbers within colored boxes indicate the HA node in which this sequence 
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Influenza A viruses (IAV) are distributed worldwide and are able to infect many 
animal species including humans and pigs (9). A reassorted IAV caused the 
2009 IAV pandemic (10), highlighted the public health risk of swine IAVs, and 
boosted the research on the molecular evolution of swine IAVs. Hence, the 
understanding of swine IAV evolution at the regional and global scales has 
improved significantly since 2009. In pigs, IAV is a major cause of respiratory 
disease and is associated with substantial production losses (16, 33, 34). 
However there is limited information available on the epidemiology of IAV in 
swine and how the genetic diversity of the virus affects IAV epidemiology in pigs, 
which is crucial to design better health interventions to control the disease in pigs 
and to reduce the risk to public health. 
 
This PhD dissertation aimed at narrowing the gap of knowledge between aspects 
of the epidemiology of swine IAVs and how viral genetic diversity affects infection 
of pig populations. We integrated basic concepts of epidemiologic methods and 
contemporary techniques for virus sequencing and bioinformatics to characterize 
IAVs under field and experimental conditions. We focused these studies first on 
commercial breeding herds to evaluate the role of specific pig subpopulations on 
the epidemiology of IAV within and between herds (chapter 2) and characterized 
the complete genome of the virus over time in these subpopulations (chapter 3). 
Then we studied the antigenic drift of IAVs in 3-week-old pigs with or without 
MDA (chapter 4), estimated the diversity of the whole genome of IAV during 
infection of vaccinated pigs (chapter 5), and characterized the complete genome 
of several IAVs co-circulating naturally over time in a large population of pigs 
after weaning. At the herd level we also focused on the epidemiological 
characterization of IAV infections (chapter 2 and 6) and we analyzed the 
complete genome diversity of the virus to address basic questions on virus 
introduction, evolution, persistence and re-infection (chapter 3 and 6). At the 
individual animal level (chapters 4 and 5) we utilized experimental studies to 
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evaluate the effects of maternally derived antibodies (MDA) and active immunity 
(vaccination) on IAV diversity and antigenic drift. We focused our studies on 
evaluating the genetic diversity of the virus during transmission among weaned 
pigs with different immune statuses because these differences are common 
under field conditions and might lead IAVs into distinct evolutionary pathways 
(63, 67, 69, 203).  
 
In chapter two, we confirmed the persistence of IAV over time in breeding herds 
and the co-circulation of more than one IAV subtype at a single sampling event. 
We proved that this long-term persistence of IAVs in breeding herds resulted in a 
higher odds of IAV infection in groups of new gilts (on farm for less than 4 weeks) 
and piglets compared to gilts (on farm for more than 4 weeks). Additionally, in 
these herds we found a strong association between IAV infection and year 
quarter indicating a seasonal pattern of IAV infection. We also showed that 
piglets and new gilts should be targets of IAV health interventions to reduce the 
impact of swine influenza on breeding herds and that there is value in having 
year around surveillance.  
 
At the individual level IAV infections in pigs do not last more than one week (3, 
16). However pig farms can test positive to IAV for prolonged periods of time 
although the mechanisms of virus persistence at the population level are not 
clearly understood. In the Midwestern USA, 90% of the farms with growing pigs 
are considered positive to IAVs and multiple IAVs are commonly found (17, 37). 
Moreover, the seasonality of IAV infections in pig herds in North America has 
been under debate given that IAVs can be recovered from pig farms year around 
(17, 75, 78). Our results confirmed that IAVs can be found for prolonged periods 
of time in swine breeding herds and supported the seasonality of IAV infection in 
pigs. Furthermore, this is the first study to take in consideration the roles that 
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specific animal subpopulations may play in the long-term persistence of IAVs in 
pig breeding herds.  
 
Multiple pig subpopulations (e.g. different ages, production stages, times of 
arrival etc.) may perpetuate the maintenance of IAV over time because they can 
be at different risks of IAV infection and harbor different IAV strains. Furthermore, 
in pig breeding herds, gilts and piglets have high turnover rates and might 
represent a continuous niche for IAV replication. Piglets are born naïve to any 
IAVs (36) and with an unknown, but likely highly variable, component of MDA 
acquired after birth. Therefore they can potentially become infected with different 
IAVs present in the breeding herd. In addition, gilts with or without active 
immunity against specific IAVs can be susceptible to IAVs present in breeding 
herds and also represent of source for introducing new IAVs to herds. Therefore 
we believe health interventions to reduce IAV transmission in breeding herds 
should target piglets before weaning and gilts at arrival. However, for these 
interventions to be effective a detailed knowledge of IAV molecular diversity at 
the herd level is required.  
 
In chapter 3, we used deep genome sequencing and hypothetical proteins to 
estimate the molecular diversity of those IAVs isolated from the breeding herds 
studied in chapter 2. We demonstrated that the continuous detection of IAV 
within pig farms could imply the presence of different genetic lineages and not 
necessarily the persistence of the same IAV over time. However, we also 
identified the same genetic lineage for prolonged periods of time. Furthermore, 
we found a dynamic distribution of IAV genotypes over time within and between 
pig subpopulations and documented the emergence, persistence, and 
subsidence of IAV genotypes. Studying the complete genome of IAVs isolated 
from pig subpopulations that are constantly fluctuating (i.e suckling piglets, new 
gilts, and gilts) increased our knowledge on the role of these populations on IAV 
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diversity. We demonstrated that different pig subpopulations within a farm could 
harbor different IAVs over time and that the co-circulation of multiple genotypes 
within a subpopulation could facilitate IAV reassortment. The complete genome 
characterization of IAVs using next generation sequencing technologies allowed 
us to differentiate IAVs over time with higher resolution than in any previous 
studies and unraveled a deeper layer of IAV genetic diversity during infection of 
pigs in breeding herds. We found multiple IAV genotypes that were either closely 
related to each other or clearly distinct. We also found several reassortant IAVs. 
Swine IAV reassortment is important because reassortment can result in 
dramatic changes in the antigenic properties of the virus (9, 41). However, it is 
not clear if this dynamic makeup of IAV genome in breeding herds, with long-
term persistence of certain IAV genotypes is due to viral or host factors.  
 
We hypothesize that there are three possible explanations for the persistence 
and genetic diversity of IAV in these pig breeding herds. First, there may be 
differences between IAVs from the same genetic lineage that enable the virus to 
evade herd immunity over time. Second, new gilts may be the source of the 
same IAV lineage and could introduce similar viral variants with each group 
introduced into the breeding herd; and third, the continuous availability of 
susceptible animals in breeding herds (newborns or new gilts) may allow the 
continuous replication of resident IAVs over time. Antigenic cartography (56, 76, 
199) between those IAVs isolated from these herds could help to test the first 
hypothesis. Additionally, sampling gilts at arrival could help evaluate the role of 
new gilts on the introduction of new IAVs into breeding herds. However, IAV 
infection, replication and transmission will likely occur in the presence of enough 
susceptible individuals. Therefore, the continuous availability of susceptible 
individuals might be the most important cause of the persistence of IAVs at the 
population level in swine breeding herds. 
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When IAV positive pigs are weaned, they can serve as a source of IAVs to 
downstream swine sites and their respective regions (37). Therefore to better 
understand the molecular evolution of IAV during infection of weaned pigs we 
evaluated the genetic and antigenic diversity of the virus under different immune 
statuses in 3-week old weaned pigs. First we compared the antigenic differences 
at the HA level of IAVs among pigs with or without MDA against IAVs (chapter 4); 
subsequently we compared the complete genome plasticity of the virus in pigs 
with active immunity to IAVs (chapter 5); and finally we studied the transmission 
pattern and IAV genome diversity during infection of pigs after weaning under 
field conditions (chapter 6). In pigs with or without MDA against IAVs (Chapter 4) 
we found that nucleotide substitutions at the HA level can happen shortly after 
infection. Furthermore, we demonstrated that these nucleotide differences 
between HAs were not limited to the HA1 region of the HA but also happened 
within the signal peptide and the HA2 region. Our results are in agreement with a 
previous study that indicated that there was no difference between the 
evolutionary trends of IAV in pigs with or without immunity against IAVs (73). 
Furthermore, using deep genome sequencing we proved that the genetic 
diversity of IAVs during infection of weaned vaccinated pigs (chapter 5) is 
dynamic, within and between pigs, and not limited to the main antigenic genes of 
the virus. Our results also illustrated the importance of the internal gene 
segments on the assessment of IAV diversity during infection of pigs. The intra- 
and inter-host variability of the complete IAV genome during infection has been 
reported recently in children (169) and at the HA level in pigs (73), horses (4), 
and dogs (5). However, to our knowledge this is the first study reporting the 
complete genome characterization of IAV during infection of vaccinated pigs 
using deep genome sequencing.  
 
MDA and humoral antibodies can change the transmission rate of IAV between 
pigs (38, 64) and variable transmission rates might influence genetic diversity 
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over time. However, the effects of humoral immune response on IAVs diversity 
may be associated with the cross reactivity of certain antibodies to different IAVs 
and their interference with an appropriate immune response (82, 142, 195, 204). 
Most weaned pigs in the contemporary swine industry are expected to have MDA 
against IAVs. Furthermore, pigs can be exposed to one or more IAVs over time 
during their lifetime and develop a variety of humoral immune response against 
IAVs (16, 18, 120).  In our studies we did not find differences in the nucleotide 
substitutions that took place at the HA level in pigs with our without MDA and we 
found that all IAV gene segments had a dynamic genetic composition during 
infection of vaccinated pigs. However, different IAV strains or vaccines might 
lead to different results. The effect of humoral immunity on swine IAV evolution 
should be further investigated because it might shape the overall genetic 
diversity of the virus and could give better tools to design health interventions at 
the population level.   
 
In chapter 6, we investigated in more detail the epidemiology of IAVs in pigs after 
weaning and attempted to identify molecular traits that might be associated with 
IAV re-infection.  We confirmed that pigs can bring IAVs to other swine farms at 
weaning and that the long-term persistence of IAVs in pigs after weaning could 
be the result of different epidemic waves of IAV infection. Additionally, we found 
that different IAVs coexisted as a population of viruses that were either closely 
related to each other in the form of viral groups (VGs) or clearly distinct 
representing distinct IAV genetic lineages. These different VGs had a clear 
distribution over time with one different VG dominating each IAV epidemic wave 
identified during the study and illustrated the complexity of swine IAV genetic 
diversity. Furthermore, in this study we had convincing evidence that indicated 
that pigs could become re-infected with viruses that differed by as few as one 
amino acid in HA although most of IAV re-infections involved viruses from 
different genetic lineages. Understanding the molecular evolution of swine IAVs 
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under field conditions is important for vaccine selection, evaluation of IAV 
reassortment, and to determine the introduction or persistence of new IAVs. 
Additionally amplifying the complete genome directly from the nasal swab in 
some studies gave us a better understanding of viral diversity in the host and 
avoided bias due to selection during virus isolation in cell cultures. 
 
Future studies are needed to test the efficacy of interventions targeting the 
aforementioned pig subpopulations. It is important to estimate the effect of 
animal movements within and between herds to determine the distribution and 
genetic diversity of IAVs. If animal movements are associated with the 
emergence and persistence of IAVs at the herd level then animal flows could be 
modified to reduce the risk of infection and maintenance. For example, sampling 
gilts at arrival, or introducing gilts at different ages or managing the flows all in/all 
out could help estimate the risk of new IAV introductions associated to new gilts 
arrival and their age at arrival. Additionally, at the herd level it will be important to 
characterize genetically and antigenically the persistent viruses in order to select 
the best vaccine available or to provide enough evidence that would require a 
policy change on swine IAV vaccine updates. Evaluation of vaccination protocols 
targeting timing, season, type of animals and type of vaccines (killed vs. live 
attenuated) are also warranted.  
 
Finally, we recognize multiple limitations in our studies and they should be taken 
into account in the interpretation of our results. First at the population level the 
external validity of our results are limited because the number of pig farms 
studied was limited and farms were conveniently selected. Therefore, it is unclear 
how our results represent pig populations across US regions. Nevertheless all 
farms for our studies were selected to represent commercial pig production sites 
in the Midwestern USA. Additionally we were not able to estimate the association 
of IAV genetic traits and epidemiological findings because these types of studies 
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require larger sample sizes and that was out of the scope of this thesis. In 
addition, in order to fully investigate the effect of vaccination on virus evolution, it 
would be important to compare the variability of the IAV genome between pigs 
with or without active immunity against IAVs. In our studies in chapter 5, we did 
not have a negative control to estimate if the genetic differences found were due 
to IAV vaccination or happened because of other host or virus factors.  
 
In conclusion we demonstrated that the complex dynamic of IAV diversity at the 
herd level is the result of the plasticity of IAV genome during infection of pigs 
regardless of their immune status. The plasticity of IAV genome during infection 
of pigs at the individual level indicated that there is a dynamic “cloud” of 
genotypes during virus replication that are closely related to each other, which 
might be translated at the population as different virus groups that can co-
circulate with other influenza A virus groups over time. This variability on IAV 
genome at the individual and population levels during transmission of the virus 
under field conditions could affect virus fitness over time and allow the 
persistence of the virus in populations at higher risk of IAV infection. We found 
that swine IAV infections are not evenly distributed among all subpopulations 
present in pig breeding herds or in pigs after weaning and demonstrated that the 
long-term persistence of IAVs in pig farms could be associated with the 
continuous occurrence of IAV epidemics at the herd level. Hence, we 
hypothesize that the most important epidemiological factor for IAV persistence at 
the population level is the continuous availability of susceptible animals to IAV 
infections that allow this dynamic cloud of IAV genotypes to replicate over time. 
We suggest that health interventions to control IAV in swine populations and 
reduce its zoonotic potential should aim to reduce the transmission and 
persistence of IAVs among those pig subpopulations that are continuously 
introduced into pig farms (new gilts, newborn pigs, and weaned pigs). The work 
presented in this thesis contributes significantly to the understanding of IAV 
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diversity, persistence and evolution in pigs and provides useful information to 
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